Effect of Niacin and Its Analogs on Growth and on the Glucose Catabolic Pathways of Staphylococcus Aureus by Wadke, Manohar V.
Loyola University Chicago
Loyola eCommons
Master's Theses Theses and Dissertations
1971
Effect of Niacin and Its Analogs on Growth and on
the Glucose Catabolic Pathways of Staphylococcus
Aureus
Manohar V. Wadke
Loyola University Chicago
This Thesis is brought to you for free and open access by the Theses and Dissertations at Loyola eCommons. It has been accepted for inclusion in
Master's Theses by an authorized administrator of Loyola eCommons. For more information, please contact ecommons@luc.edu.
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.
Copyright © 1971 Manohar V. Wadke
Recommended Citation
Wadke, Manohar V., "Effect of Niacin and Its Analogs on Growth and on the Glucose Catabolic Pathways of Staphylococcus Aureus"
(1971). Master's Theses. Paper 2532.
http://ecommons.luc.edu/luc_theses/2532
Effect of niacin and its analogs on growth and on the 
glucose catabolic pathways of Staphylococcus aureus 
by 
A Dissertation submitted to the faculty of the graduate 
school of Loyola University of Chicago, in partial 
fulfillment of the requirements for the degree 
of Doctor of Philosophy 
UBllARV 
LOYOLA U~ !:\':1?.::ITY MEDICAL CENTER 
Effect of niacin and its analogs on growth and on the glucose catabolic path-
ways of Staphylococcus aureus. 
Monohar WADKE 
Loyola University of Chicago Stritch School of Medicine, Maywood, Illinois 
Advisor: Dr. H. J. Blumenthal 
~· aureus catabolized glucose by both the Embden-Meyerhof (EM} and the 
hexosemonophosphate (HMP) pathways, as determined with 14c~labeled glucose. 
The relative activities of these pathways, and of the TCA cycle, were in-
fluenced by the inclusion of niacin and/or thiamine in the growth medium. 
When > 0.25 µg/ml of niacin was added to 2% Vitamin-free Casitone, the pro~ 
portion of glucose metabolized via the HMP pathway by 2_. aureus was stimu-
lated 3-fold. When O.l µg/ml of niacin was added, the growth was maximally 
stimulated but increased NAD(P) synthesis or HMP pathway activity was not 
observed. Under growing conditions, increased glucose oxidation via the HMP 
pathway and TCA cycle activity were correlated with the increased synthesis 
of NADP-specific glucose-6-P dehydrogenase and isocitrate dehydrogenase, 
deficient cells, metabolic changes similar to those in growing cells occurred, 
even in the presence of protein inhibitors such as chloramphenicol, puromycin 
or actinomycin D. Since the specific activities of the enzymes tested remained 
unchanged under conditions that precluded new enzyme synthesis, the enzyme 
levels were not the limiting factors for glucose oxidation via the HMP pathway, 
In order to determine if either NAO and/or NADP were regulating the HMP 
pathway activity, the staphylococcal suspensions were starved for 6 hr in 
buffered-glucose (pH 7.0), under conditions that allowed the NAO to decrease 
and NADP to remain constant, During the period of starvation the initial NAO 
level decreased to l µmole/g and the percent of ~lucose oxidized via ·the HMP 
pathway decreased to 9%, reaching a value of 6% after 6 hr at which time the 
NAO content was further ~educed. to 0.5 µmole/g. When niacin was added, the 
NAO levels and the HMP activity in these cells were increased to ·1,2 µmoles and 
16%, respectively, after 2 hr of additional incubation. These results indicate 
that NAO is regulating the activity of this expandable (6 to 22%) HMP pathway, 
by increasing NADP turnover via the transhydrogenase system. 
.. 
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Any of several 1-,2-,3- and 4-substituted niacin analogs completely 
replaced the niacin requirement for both growth and the HMP pathway utili-
zation when added at high concentration (ca. 1000 µg/ml} to either a 
synthetic medium or Vitamin-free Casitone supplemented wtth thiamine. On 
the basis of their effects on growth and on the HMP pathway the analogs 
we;·e classified into 4 groups. The 22 goup I analogs, including pyridine-N-
oxide, pyridine-3-sulfonic acid and 3-acetylpyridine, stimulated both growth 
and the HMP pathway maximally while the 9 group II analogs, such as picolinic acid, 
stimulated growth and the HMP pathway to a lesser extent, There were 13 analogs 
from group III, including 6-hydroxynicotinic acid, that were without effect 
while 4 analogs from group IV, including 6-aminonicotinamide, were inhibitory. 
Parallel experiments in this laboratory using labeled quinolinic acid, isoniazid 
and pyridine-N-oxide indicated that the.analogs were converted to NAD(P) and 
llUI. l..O 1.i1t:il a11aloqs, On tile UdSb of the j.)er1i1t:aL;li1.v .")\,U~;C.") VV;l.;l \.;IC 
labeled compounds and 14c-niactn, it was suggested that the need for high 
concentrations of analogs for growth was due to the absence of active transport 
for these compounds and the analogs entered the cells by simple passive diffusion 
to cause biochemical changes .similar to those caused by niacin, 
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INTRODUCTION 
Glucose is the main metabolic fuel for living cells, pro-
viding both energy and intermediates for various biosynthetic 
reactions. Al though important. insights have already been 
obtained during the past decade into the regulatory mechanisms 
which influence microbial activities such as amino acid bio-
synthesis, the same degree of knowledge is not available for 
the regulation of carbohydrate metabolism. In bacteria the 
control mechanisms for individual glycolytic pathways, particu-
larly the Embden-Meyerhof (EM} pathway, are known to a moderate 
degree. For example, when cells catabolize glucose via the EM 
pathway, phosphofructokinase plays an important regulatory role 
glucose from smaller molecules through a reversal of the EM 
pathway, then the enzyme fructose-1,6-diphosphatase plays the 
important role of controlling the activity of this pathway. 
The situation is more complex when we wish to learn about the 
factors that control the amount of glucose being utilized by 
the two pathways that can both utilize glucose within the 
cells, the EM and the hexosemonophosphate {HMP) pathways. By 
comparison, very little is known about such regulatory factors. 
Although the importance of the vitamins niacin and thiamine 
in microbial glycolysis is known, their effects on the indivi-
dual- glycolytic pathways are relatively unexplored. Regulation 
of the HMP pathway by the availability of NADP and by the levels 
1 
--
p 
2 
of some glycolytic enzymes has been demonstrated in various 
bacteria. However, NAD has not been shown to be involved in 
the control reactions of the pentose phosphate pathway. The 
lack of information on the role of NAD from a regulatory point 
of view mainly stems from the fact that NAD does not generally 
serve as a coenzyme in the HMP pathway. 
The present study is an extension of an earlier study 
which had shown that the addition of niacin resulted in a 3-
to 4-fold stimulation in utilization of the HMP pathway of 
s. aureus and a concomitant decrease in the percentage of 
glucose metabolized via the,.E;M pathway. In order to investi-
g ..... L .. : ;:;-.;ln<:. 0£ th..:.: factors involved in t.be .Lt::i::f u:i..cu • .i.vu 0;: ':I :i..u. .... vSb 
oxidation via the HMP pathway, the levels of glycolytic enzymes 
and of nicotinamide coenzymes were studied in cells under 
conditions in which the HMP' pathway was increased or decreased. 
Also, niacin analogs were employed in these studies in an 
attempt to obtain more information about the regulatory role of 
NAD(P). Since niacin analogs were found to completely replace 
niacin, some studies on the mechanism of niacin replacement by 
the analogs were also initiated. 
--
~·· 
I. REVIEW OF LITERATURE 
.Glycolysis usually serves to satisfy various cellular 
requirements such as energy and precursors for biosynthesis. 
In addition glycolysis serves to convert these precursors 
into useful intermediates for the appropriate cellular re-
actions. Stapnylococcus aureus metabolizes glucose aerobically 
or anaerobically by both the Embden-Meyerhof (EM) and the 
hexosemonophosphate (HMP) pathways (88, 113), with the EM being 
the major pathway. Under aerobic conditions the pyruvate is 
further oxidized to water and co2 via the tricarboxylic acid 
(TCA) cycle (94,111). So far there is only negative evidence 
in the literature for the occurence of the ~ntner-Doudoroff 
c,t<:i>J n;:it:hwr:iv in staphylococci (113). 
The HMP pathway (also known as the pentose phosphate 
pathway or the pentose cycle) for glucose catabolism is widely 
distributed in microorganisms. The pathway provides a route 
of glucose oxidation that is independent of the TCA cycle and 
of glycolysis by the EM pathway. It is a generator of NADPH 
and of 4 and 7 carbon sugars necessary for various biosynthetic 
processes. It is also a source of ribose, an intermediate 
• product of this pathway that can be used for synthesis of 
nucleic acid. 
Operation of the HMP pathway along with the EM pathway 
during glycolysis became apparent in a wide variety of living 
3 
cells. During the investigation of biochemical changes in 
s. aureus, some evidence indicating the operation of the HMP 
pathway was obtained, by measuring the rate of formation of 
14co2 from glucose-1-14c and glucose-6-14c (19, 38). 
Oxidation of glucose has been st.udied in s. aureus in 
the presence or absence of arsenite, an inhibitor which 
causes the accumulation of pyruvate and thus blocks the 
further oxidation of pyruvate via the TCA cycle (113). In 
4 
the presence of this metabolic inhibitor, considerable amounts 
of 1 4co2 were recovered during the oxidation of glucose-1-14c 
and glucose-u-14c. Thus the results of these studies demon-
~l..l.c:l1..t:u 1..ut: ::.irnultant:ou::. Uf:Jt:rai.ion o.i: the hlvlP pathway alum~ 
with the EM pathway and established the importance of the 
HMP pathway in staphylococcal carbohydrate metabolism. 
Estimation of the glucose catabolic pathways also 
indicated that about 64% of the glucose was oxidized via the 
HMP pathway by resting cell suspension previously grown in a 
broth lacking glucose . When glucose was added to the 
nutrient broth, glucose oxidation through the HMP pathway 
decreased from 64% to 34%. In addition there was an inhibi-
tion of the TCA cycle. Studies on various individual glyco-
lytic enzymes were also made and evidence for re9ression 
(i."e., inhibition or suppression of the synthesis of enzymes) 
was obtained when glucose was present in the medium (16,49, 
113). This effect of glucose has also been reported .for 
other microorganisms, such as Bacillus subtilis, Escherichia 
coli and Thiobacillus intermedius (36,39). 
-
Glucose repression of cellular activities is not limited 
to microbes. For instance, glucose inhibited the glucose 
oxidation via the TCA cycle in ascites tumor cells: however, 
it increased the oxidation of carbon-1 of glucose, presumably 
by the HMP pathway (95). At the same time it was also 
demonstrated in s. aureus that addition of glucose to the 
growth medium reduced both the oxidation of glucose by the 
HMP pathway and the subsequent oxidation of pyruvate via the 
The iron content of the medium also has a significant 
effect on the glycolytic pathways in staphylococci (116). 
The metabolic activites of s. aureus grown in an iron-poor 
and in an iron-rich Trypticase medium, with and without 
addition of glucose,were compared. It was found that i~ the 
absence of glucose, iron-rich cells oxidized glucose and 
other substrates more efficiently than did the cells grown 
in the iron restricted medium. The addition of glucose 
under the same conditions resulted in severe reduction of 
the oxidative capacity of the iron-restricted cells, compared 
to ·that of iron-rich cells. From these results it was conclu-
ded that the metabolic activity of S. aureus was affected by 
5 
both the amount of iron in the medium and by the presence or 
absence of glucose. 
The effects of a number of different physical and physio-
logical conditions that might alter the glycolytic pathways 
in s. aureus have been studied by various workers and reviewed 
by Blumenthal (5). The effect of vitamins on the glycolytic 
pathways have not been extensively investigated in micro-
organisms. A thiamine deficiency in red blood cells is 
known to diminish the activity of the HMP pathway since DPT, 
the coenzyrne form of thiamine, is a coenzyme for the HMP 
pathway enzyme transketolase. It has been shown that. the 
""'C<l.i.:::.lon of thiamine Lo thiamine deficient. ..::c.;.d Llv...Jd <.;ell;:,; 
stimulated the activity of transketolase which iri turn 
stimulated the HMP pathway (102). 
Earlier studies with staphylococci yielded information 
of a general nature. A certain relationship between niacin 
and thiamine and the utilization of glucose by staphyl?cocci 
was observed (61). In order to elucidate the specific roles 
of these two vitamins in glucose metabolism by this organism, 
staphylococci were grown in 10% Vitamin-free casein hydroly-
sate containing constant amounts of niacin and thiamine 
(1.0 µg/ml). It was demonstrated that there was an active 
aerobic growth of staphylococci in the presence of niacin 
alone, with only partial utilization of glucose. The amount 
6 
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of glucose metabolized was only about 40% of the amount used in 
the presence of niacin and thiamine. Analysis of the end 
products of glucose catabolism also indicated that thiamine 
catalyzed the oxidation of pyruvate only in the presence of 
niacin; however, specific effects of these two vitamins on the 
glucose catabolic pathways were not investigated. 
The formation of niacin coenzymes, NAO and NADP,from niacin 
with the subsequent stimulation of glycolysis in S. aureus has 
been noted (47). During the investigation on the effects of 
some niacin analogs on glycolysis, marked glycolytic inhibition 
as a result of the addition of niacin analogs was noted. Based 
ui1 1...i:it:!::>t~ resuJ..ts it was suggested that the ana.Logs probab.Ly 
acted by interferring with the staphylococcal synthesis of 
nicotinamide coenzymes. Montiel and Blumenthal (81), using 
labell~d glucose to estimate the pathways in living cells, 
showed that the addition of niacin and thiamine to the growth 
medium had significant effects on the degree of operation of 
the EM and the HMP pathways. They reported that the addition 
of ni.acin to the growth medium increased the operation of the 
HMP pathway, while both niacin and thiamine were necessary for 
maximal stimulation of the TCA cycle activity. The effect of 
niacin and thiamine on the coenzyme levels was investigated 
(44)". It was shown that when niacin was added to the medium, 
there was a 15- to 30-fold increase in NAD level and only a 
8 
2-fold increase in NADP, NADH and NADPH levels in staphylococci. 
This increase in the coenzyme contents due to the vitamins was 
also followed by stimulation of glycolysis ins. aureus (45). 
Participation of glucose catabolic pathways in micro-
organisms. Wang et al. (119) introduced the radiorespiro-
metric method for the estimation of the glucose catabolic 
pathways. This method has been widely and successfully used 
to evaluate the glycolytic pathways in many different bacteria. 
Based on this technique it was reported that in Pseudomonas 
natrigens 92% of the glucose was catabolized via the EM 
pathway, whereas 8% was oxidized via the HMP pathway. The 
Escherichia coli was 72% and 28%, respectively (23). On the 
other hand, complete absence of the EM and the ED pathways 
was noted in Acetobacter suboxydans, with all of the glucose 
catabolized via the HMP pathway (60). Similarly, the EM and 
the HMP pathways were shown not to be operative in Pseudomonas 
saccharoohila (12). When S. aureus was grown in Trypticase 
soy broth (which contains glucose), the simultaneous participa-
tion of the EM and the HMP pathways was 88.7% and 11.3%, 
respectively (4). Montiel and Blumenthal (81) studied the 
effects of vitamins on glucose catabolic pathways in various 
strains of S. aureus and ~- epidermidis. Their findings 
demonstrated that in the presence of niacin and thiamine 
9 
roughly 14-40% of the glucose was oxidized via the HMP pathway 
by staphylococci. 
Generally, in purely biosynthetic pathways the major 
control exerted is the negative feedback control. In this 
type of control process, the end product or the metabolite 
represses the synthesis and/or inhibits the activity of the 
first enzyme of that pathway. In catabolic pathways, however, 
the activity of initiating enzyme is generally controlled by 
compounds which serve as indicators of the energy state of a 
cell such as inorganic phosphate, pyrophosphate, purine or 
pyrimidine nucleotides. Occurance of cooperative feedback, 
., ..• ~ : . =·· ': ,~ 
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tion have been studied in detail (84, 90, 127). 
The various control mechanisms involved in amphibolic 
pathways (i,e., metabolic pathway pro_viding both anabolic and 
catabolic functions) have been recently reviewed by Sanwal 
(101). There are various diverse control mechanisms present 
which differ in details from microbe to microbe, although the 
main types of control mechanisms are the same. This is in agree-
• 
rnent with the concept of "unity of biochemistry". For example, 
citrate synthase in _animal (SO), in Yeast(89) or in B. subtilis 
(28) is inhibited by ATP, while in E. coli it is inhibited by 
NADH and a-ketoglutarate. In the case of aerobic Gram-positive 
bacteria such as staphylococci, the enzyme is not regulated by 
L 
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either ATP or NADH, and probably some other different control 
mechanism may be present in these organisms. Moreover, many of 
the control mechanisms have been studied extensively only in 
E. coli and in few other Gram-negative bacilli. More detailed 
- -
studies are needed in other groups of bacteria before a 
generalization can be made about the regulatory process. 
Recently it was reported that fructose-6-phosphate, glucose-6-
phosphate and AMP inhibited the activity of two enzymes in the 
aspartic acid family of E. coli (2). This example of the 
control of amino acid biosynthesis by glycolytic intermediates 
of the EM and the HMP pathways again indicates the extent and 
importance of this type of control mechanis~_ 
~ .. , . ; 
There is considerable evidence indicating that the activity 
of the hexosemonophosphate pathway may be partly controlled by 
the supply of NADP. The presence of artificial electron 
acceptors (9) or the supply of substrates which require NADPH 
for their metabolism (42, 57) can increase the rate of formation 
of 14 co 2 from glucose-1-1 4c, suggesting active operation of the 
HMP pathway. Similar effects have been observed in other 
animal tissues such as erythrocytes (8), corneal epithelium (59) 
and ascites tumor cells (121). The HMP pathway in erythrocytes 
was shown to be dependent on the availability of NADP (18). 
Later Smith and Stourman, (110) using a hemolysate preparation 
of red blood cells, confirmed the enhancement of the HMP pathway 
activity following the addition of NADP to the extract. High 
l 
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activities of glucose-6-phosphate and 6-phosphogluconate 
dehydrogenases together with the marked increase which occurred 
in the oxidation of carbon-1 of glucose when artificial electron 
acceptors were added to the medium indicated that the activity 
of the HMP pathway was limited by the supply of NADP (79}. 
The operation of the HMP pathway in P. natrigens was rate 
limited by the supply of NADP (24}. This was based on further 
studies on the rate of oxidation of NADH and NADPH and the 
activity of transhydrogenase in crude extracts from a number of 
organisms in which estimates of the relative degree of operation 
of the EM and the HMP pathways had already been made. A strong 
cor:r·:::ls..Lion t:Jas found between Lti.ose :micrubes whose extracts 
possessed an active NADPH oxidase and transhydrogenase and 
those organisms which predominantly oxidized glucose through 
the HMP and/or ED pathways. The activities of ~hese .enzymes 
were absent in the organisms mainly utilizing glucose by the 
EM pathway. Rate limiting effects of NADP might also be over-
come by the presence of two initial enzymes of HMP pathway 
that could utilize either NAD or NADP as cofactors (13}. Such 
enzymes are extremely rare. 
Thus the activities of the glycolytic pathways can be 
controlled by the availability of cofactors as well as by the 
levels of adenine nucleotides. In addition to this control by 
the nucleotides, the regulation of these pathways can be 
12 
influenced by the variation in the amounts of certain key ·enzymes 
of the pathway. Osmond and ApRees (87) suggested that in yeast, 
control of the HMP pathway occurred by variation in the amount 
of some enzymes. They tested the activities of certain enzymes 
of both EM and the HMP pathways in extracts of yeast grown either 
in simple medium containing nitrate as the sole nitrogen source, 
or in a complex medium containing all of the amino acids. 
Measurement of the enzyme activities was also correlated with the 
estimation of 14co2 production from -1-14c and -6-14c-glucose. 
Their findings demonstrated that the activities of G6PD and 
transketolase were significantly higher in extracts of yeast 
on the complex amino acid medium. Increased enzyme activities 
paralleled increased 14co2 liberation from glucose-1-
14
c, 
providing a rough measurement of the HMP pathway activity. 
Similarly, yeast cells were first grown in the complex medium 
and then transferred to the simple med·ium; this also resulted 
in the increased synthesis of the same enzymes of the HMP 
pathway. On the basis of these results they suggested that the 
increased amount of G6PD and transketolase- indicated that 
adaptation to carbohydrate oxidation via the HMP pathway in-
volved synthesis of more enzymes. 
Regulation of the glycolytic pathways also depends on the 
induction, activation or inhibition of the glycolytic enzymes 
by vitamins, metabolites or coenzymes. For instance, induction 
r 
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of G6PD synthesis by NADP, NADPH and by other compounds, such 
as nitrobenzimidazole, has been observed in animal and microbial 
cells (3, 105), indicating their role in the glycolytic control 
mechanisms. Thiamine, in the form of diphosphothiamine {DPT), 
has been shown to induce the synthesis of pyruvate decarboxylase 
in yeast, with a resultant increase in the rate of glycolysis 
(123). DPT is actually the coenzyme for pyruvate decarboxylase 
apoenzyme. This finding was based on the observation that 
pyruvate decarboxylase activity increased by 50% during the 
incubation of yeast cells with glucose and thiamine and by 300% 
when the cells were incubated with glucose, thiamine and nitrogen 
induced by thiamine, was prevented by the inclusion of proflavin, 
p-fluorophenylalanine or 5-fluorouracil in the incubation medium. 
These results indicated that the reason for the higher activity 
of pyruvate decarboxylase, after incubation with thiamine, was 
a result of the stimulation of the de novo synthesis of the 
enzyme and not of an activation of preexisting enzyme molecules. 
There are also other examples of this type in animal tissues 
(37) • 
Glucose-6-phosphate dehydrogenase (G6PD) catalyzes the 
oxidation of glucose-6-phosphate and thus introduces hexose into 
the pentose cycle. Since this is an important branching step in 
hexose metabolism, it is likely that this enzyme would be sub-
~ jected to regulatory control. The G6PD from Pseudomonas 
r 14 
aeruginosa was strongly inhibited by ATP, GTP and dGTP by 
decreasing the binding of the substrate to the enzyme and it 
was suggested that adenine nucleotide control of the activity 
of G6PD might regulate the overall degradation of glucose 
under conditions requiring gluconeogenesis (70). A similar 
inhibition of G6PD of E. coli by ATP was noted, indicating 
that adenine nucleotide control of activity of allosteric 
enzymes may be of general importance (1). Recently it was 
reported that the activity of the G6PD of E. coli was inhibited 
in an allosteric manner by NADH. Although this inhibition of 
G6PD by.· NA.DH has not been opi;;er.ye9 i.n ot,he.r, ,bact,e,r~}lJ . species 
tPst~dr it does appear to play a signific::mt "l"'nlf> i.n C"O:nt:rnJling 
the enzyme activity in E. coli (100). 
If a cell has excess of ATP, it would appear logical to 
assume that it would have a feedback mechanism to slow down the 
glucose catabolism that is leading to the generation of more ATP. 
It was demonstrated that ATP and GTP were competitive inhibitors 
of G6PD, the important HMP allosteric enzyme in ascites tumor 
cells, while only 6PGD was sensitive to GTP (7). Schindler and 
Schlegel (103) concluded from their studies of G6PD from various 
microorganisms that G6PD functioned only in catabolism and that 
these enzymes were subjected to adenylate control with ATP as 
a negative allosteric effector. It is generally believed that 
phosphofructokinase is an important regulatory enzyme for the 
Lactivity of the EM pathway and this it also is inhibited by 
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excess ATP and activated by AMP (117). If ATP is capable of 
inhibiting the key H..l'1P pathway and the key EM pathway enzymes, 
high cellular levels of A'I'P should depress the total amount of 
glucose catabolism in the cell. This provides a sensitive and 
efficient mechanism for the regulation of the metabolic path-
ways (72, 93). 
There is very little evidence regarding the control of 
other enzymes in the HMP pathway. The activity of transketolase 
was found to be limiting the HMP pathway activity in thiamine-
deficient red blood cells (102). In addition, it has been 
reported that transketolase was the rate-limiting enzyme in 
1.-\ v, 
85). In yeast, variation iri transketolase activity was observed 
to parallel the degree of operation of the HMP pathway (87). 
Significance of this increased activity of transketolase may be 
that it prevented the accumulation of erythrose-4-phosphate, an 
inhibitor of glucose-phosphate isomerase, and allowed increased 
activity of the HMP pathway without any inhibition of the overall 
glycolytic rate. 
The tricarboxylic acid cycle (TCA) functions mainly as an 
energy yielding process and also provides many precursors for 
cell biosynthesis and growth. The intermediates and biochemical 
reactions of this cycle have been extensively studied in numerous 
biological systems {67). Since many biosynthetic pathways 
L 
• 
16 
originate from the TCA cycle and many reactions of the cycle are 
important for the production of energy, it is likely that many 
of the enzymatic steps of this pathway are subjected to regu-
lation by various effectors. One of the allosteric enzymes of 
this pathway has been found to be isoci trate dehydrogenase (ICD.>. 
This allosteric enzyme can thus increase or decrease the activity 
of the TCA cycle (75, 98, 99). 
The control mechanisms for the activation of ICD are not 
fully understood. It has been demonstrated in Neurospora, and 
also in yeast (98) that the affinity of th~ substrate for the 
enzyme increases dramatically in the presence of AMP. This 
regulation of the TCA cycle. 
It has been suggested that the tricarboxylic acid cycle may 
be rate limited by the supply of NADP, since isocitrate 
dehydrogenase was shown to require NADP as a cofactor (14). 
In microorganisms two types of isocitrate dehydrogenases have 
been reported (101). NAO-specific isocitrate dehydrogenases 
are part of the normal function of the TCA cycle in the oxidation 
of substrate for the generation of energy~ whereas NADP-specific 
isocitrate dehydrogenases are coupled to biosynthetic pathways 
originating from TCA cycle (34, 99). 
Both niacin and thiamine have been considered to be 
essential vitamins for the growth of S. aureus for over 20 years. 
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In fact, it was with S. aureus that niacin was first proven to 
be a vitamin requirement for living cells (63). Although niacin 
remains as an absolute vitamin requirement for the growth of 
5. aureus, thiamine is no longer considered as an essential 
vitamin. Idriss and Blumenthal (48) d~veloped a new thiamine-
free synthetic medium for S. aureus which supported a moderate 
growth of staphylococci (OD, 0.2 in 10 hr) in the complete 
absence of thiamine when pyruvate or glucose was the carbon 
source. However, added thiamine still stimulated growth in an 
otherwise complete medium. Thus the inclusion of thiamine in 
the medium tripled the amount of growth • 
.i:ulluwiw:.i 1...Ht: iHiL.Lal. ui&l;O\fer.y C:lW:i iUt::!il\.if.L~d.t....LUU u.i. l..Ut::::>t:: 
vitamins, a survey was made of the ability of several compounds 
closely related to niacin and thiamine to replace them as a 
growth factor for the growth of various bacteria (62, 63, 68, 
69). The results of the studies showed that only a very limited 
departure in structure of the two vitamins could support the 
growth of staphylococci. S. aureus was the original microbe 
that was shown to require preformed nicotinic acid for growth. 
The utilization of a number of compounds related to nicotinic 
acid by various bacteria (i.e.,~- aureus, Proteus vulgaris, 
Shigella dysenteriae and Lactobacillus plantarum) was studied 
by a.number of workers (26, 27, 62, 73, 91); the results of 
these investigations have been well summarized by Koser (66). 
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The utilization of a number of isomers of nicotinic acid by 
5• aureus was studied, using amino acid-glucose medium (27, 69). 
-
The analogs were tested in the presence of thiamine (0.005 µg/ml) 
in the medium. Using concentrations of niacin isomers up to 2.0 
µg/ml, it was reported that with the exception of nicotinuric 
acid, none of the following compounds could replace niacin in 
supporting growth of s. aureus: nicotinyldiethylamide, 
quinolinic acid, 2-methylpyridine, or isonicotinic acid. On the 
basis of these results it was concluded that the ability of 
s. aureus to utilize.compounds related to niacin was very limited 
(68, 69). 
Knight and Mcilwain (63) investigated tne abi~ity or a 
series of pyridine derivatives to replace niacin, by adding them 
to a basal medium which was nutrionally adequate for the growth 
of §_. aureus,· except for niacin. All the analogs were tested 
at a concentration of 10-4M in the presence of excess thiamine 
(l0- 7M); the growth was measured for a period of 3 days under 
aerobic conditions. They reported that quinolinic acid, 
picolinic acid, isonicotinic acid, pyridine-3-sulfonic acid, 
• 
3-picoline and several other related pyridine derivatives could 
not replace niacin in supporting growth of s. aureus. On the 
basis of these results they suggested that niacin and thiamine 
were highly specific in their growth requirement for s. aureus. 
L . 
Pyridine-3-sulfonic acid (PSA), the sulfur analog of 
niacin, was ineffective in replacing the niacin requirement 
for the growth of Proteus species. However, it strongly 
inhibited the growth of s. aureus, presumably by acting as 
an antimetabolite. The effect of various concentrations of 
pSA on the growth of s. aureus in the synthetic medium 
containing niacin and thiamine was studied (78). It was 
found that the addition of PSA (10-2M) to the medium contain-
ing nicotinarnide (10-6M) resulted in growth inhibition that 
was reversed by th~ ~dditi9h of higher arn9unt~.of niacin.or 
, ,., ·' •. . •'-1' ·•·•·'" • II" .·' ,_ 
niacinarnide. On the other hand, it was reported that PSA and 
its amide had some growth stimulating action on ~- vuigaris 
-ands. aureus at a relatively high concentration -(97). Simi-
larly, complete replacement of the niacin requirement of 
Shigellae species by PSA -Cl mg/ml) has been observed (92). 
The mechanism by which PSA substitutes niacin is not 
clear. It is possible that there is either a conversion of 
PSA to niacin or that PSA itself is incorporated to yield a 
coenzyme analog which is biologically functional. 
Wooley (126) observed that 3-acetylpyridine (3-AP) was a 
niacin antagonist in animals. 3-AP differs from niacin by 
the replacement of an acetyl group for the carboxyl group. 
Although this analog could not support the growth of a 
number of microorganisms, it did substitute niacin to some 
L 
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extent for some niacin-requiring strains of dysentry bacilli 
(82). The toxicity of 3-AP in animals was shown to be due to 
the formation of abnormal coenzyme. For example, the formation 
of the 3-AP analog of NAD in the brain and in the spleen of 
mice was demonstrated after the administration of 3-AP (53, 54). 
In this case, the 3-AP replaced the nicotinamide moiety of NAD. 
The 3-AP analog of NAD was the first one that was found to 
be active with a number of dehydrogenases. 3-Acetylpyridine-
NAD (APNAD) was shown to serve as a coenzyme with yeast alcohol 
dehydrogenase at approximately 10% of the rate at which NAD 
served, while pyridine-3-aldehydeNAD (Py-3-NAD) reacted at a 
consiaerably s.Lower rate. With horse alconol. aehydrogenase or 
-
with glutamate dehydrogenase, both APNAD and Py-3-NAD reacted 
more rapidly than the normal NAD (53, 54). 
A large number of compounds related to dipicolinate, an 
analog of niacin, were investigated for their ability to replace 
dipicolinate in restoring sporulation in a mutant strain of 
Bacillus megaterium. Of the compounds tested, only 4-H-pyran-2, 
6-dicarboxylic acid and dipicolinic acid-N-oxide were effective 
in restoring sporulation and heat resistance. However, 4-H-
pyran-2, 6-dicarboxylic acid was found to be more effective than 
the natural compound, dipicolinate, in these respects (31, 32). 
In animals, 6-aminonicotinamide (6-AN) has been shown to 
be a potent analog of niacin. The toxic effects of 6-AN upon 
L 
injection into animals are due to its incorporation into 
analogs of NAD and NADP (52). Formation of 6-AN-NAD has also 
been demonstrated in vitro (21, 22) and it is a competitive 
inhibitor of several NAD- and NADP-dependent enzymes (17). 
Dietrich et al. (22) studied the effect of 6-AN administra-
tion on the activities of several NAD linked enzyme systems 
in animal adenocarcinoma and found that the activity of 
lactate dehydrogenase was unaffected by the coenzyme analog, 
while 3-phosphoglyceraldehyde dehydrogenase and a-keto-
glutarate oxidase activities were markedly inhibited. 
Concomitantly, there was a significant decre~se in the 
-other organs. Decreased levels of NAD and NADP following 
the administration of 6-AN, were also observed in ascites 
tumor cell~ (12). 
21 
There was a considerable decrease in the release of 14co2 
from glucose-1-14c, when 6-AN treated animal tissues were used 
for the metabolic studies (40, 41). This and other data 
indicated that there was an inhibition of the two initial 
• 
NADP-dependent enzymes of the HMP pathway in vivo. The 
inhibition was shown to be more significant at the 6PGD level 
than at the G6PD level. This was based on the finding that 
larger amounts of 6-phosphogluconate were accumulated in the 
brain of 6-AN treated animals compared to glucose-6-phosphate. 
L 
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various other biochemical reactions outside the HMP pathway, 
are also inhibited by 6-AN. For instance, it has been reported 
that there was an inhibition in the incorporation of glucose 
intermediates into DNA, P.NA and proteins. However, these 
adverse effects were probably secondary to the inhibition of 
the HMP pathway activity (64). 
The effects of niacin analogs on the growth of various 
niacin-requiring microbes in a synthetic medium containing 
minimal amounts of niacin, were investigated (114). The 
results of these studies indicated that the growth of strepto-
cocci, E. coli and Lactobacillus plantarum were completely 
inru.oit:ecl .Uy .::>-i.Luu.r.unit:;uL..J..uil..:! ac.J..d added ct <.:;u1:i~t:!Hi.:..J..a1..i.1..h1 v.i.. 
0.05 to 1.0 µg/ml, but this concentration failed-to inhibit 
the growth of s. aureus. However, 5-fluoronicotinamide in the 
same concentration was most inhibitory to the growth of 
~· aureus, E. coli and of streptococci. The growth of L. pla-
ntarum, S. aureus, P. vulgaris and of E. coli was inhibited 
by five halogenated nicotinic acid derivatives in the following 
order of decreasing effectiveness: 5-fluoro-, 5-bromo-, 
2-fluoro- and 6-fluoronicotinic acid (47). Such inhibition 
of microbial growth was reversed by the addition of niacin, 
niacinamide or NAD to the growth medium. According to 
Streightoff (114) replacement of the 5-fluoro group with an 
amino, bromo, chloro, dimethylamine, hydroxyl or other 
L 
groups resulted in loss of inhibition of growth of strepto-
cocci. Changing the fluoro group from 5th to 6th position 
on the pyridine ring also r~sulted in a compound with very 
little inhibitory activity. In comparison when amino 
group was on the 4th or 6th position the compound exhibited 
significant growth inhibitory activity (114). 
Since there are contradictory reports in the literature 
on the growth effects of these niacin analogs, studies were 
23 
undertaken to explore their effects on the growth of s. aureus. 
Niacin analogs such as 3-acetylpyridine and 6-aminonicotinamide 
have been studied extensively in animal system and their toxic 
0ttributed to change= 
- bolic pathways and in enzyme and coenzymes involved in these 
pathways. Therefore, it was of interest to investigate the 
effect of these analogs on the glucose catabolic pathways 
and on the coenzymes in S. aureus. This ~ould give us an 
excellent oppertunity to study the relation of the glycolytic 
enzymes, nicotinamide coenzymes NAD(P) or analogs of these 
coenzymes to the glucose catabolic pathways. 
L 
II. MATERIALS AND METHODS 
Bacterial cultures. Most of the experimental work was 
performed with Staohylococcus aureus, strain Towler, originally 
obtained from Dr. w. c. Noble, St. Mary's Hospital Medical 
school, London, England. Strain 18Z was received from Dr. F. 
Kapral, Ohio State University, Columbus, Ohio, while strain 
23 was received from Dr. s. Cloutier, University of Montreal, 
Canada. S. aureus serotypes 1 to 4 and S. epidermidis ATCC 
115 and 12228 were obtained from Dr. W. w. Yetis of this 
department. Strains of~· flexneri, P. vulgaris and P. morgani 
~~-~ ~~taine~ ~~om the dcpart~ental cultur: ::l!:~~~:~-
The stock cultures of the organisms were maintained on 4% 
Trypticase soy agar {Baltimore Biological Laboratories, 
Baltimore,_ Maryland) at 4 C and were transferred to fresh 
slants every 2-3 weeks. 
Media 
a. Preparation of liquid media. Vitamin-free 
Casi tone {Difeo Laboratories, Detroit, Michigan.) was use_d 
• 
extensively throughout the studies. The medium was prepared 
in 2% concentration in distilled water and dispensed in 100 ml 
aliquots into specially cleaned 250 ml Erlenmeyer flasks. All-
flasks were cleaned by boiling in distilled water containing 
2% (V/V) Fl-70 Biograde detergent(Fisher Scientific, Pittsburg, 
L 24 
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pa.) and rinsed several times with distilled water. This step 
was necessary in order to eliminate any traces of vitamins 
remaining in the glassware. The medium was sterilized by 
autoclaving at 121 C for 15 min. Sterile vitamin solutions 
were added aseptically to these flasks, whenever needed. The 
preparation and concentration of the vitamins used are 
described later. 
Preparation of synthetic medium. · The synthetic medium of 
Idriss and Blumenthal (48) was prepared and sterilized by 
membrane filtration (type HA, 0. 45 µ pore size, _Millipore 
Filter Corp., Bedford, Mass.). Autoclaving of the medium was 
- the medium. The complete composition of the medium has been 
described by Idriss and Blumenthal (48). 
Preparation of vitamins and niacin analogs. Niacin, 
thiamine and the niacin analogs were separ~tely prepared and 
sterilized by membrane filtration. For the sterilization of 
the vitamins or analogs, sterile Millipore 'Swinnex' filters 
containing a membrane (0.45 µ pore size ) were used. Stock 
solutions of the vitamins and niacin analogs were prepared 
in deionized distilled water in various concentrations and 
were stored at 4 c for not more than 2 weeks. The vitamins 
or. the analogs were added aseptically to the sterile medium 
when it was cool. 
L 
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Growth conditions. In all experiments the starter culture 
was prepared in the following manner. A loopful of cells from 
the stock culture was plated on a Trypticase soy agar plate 
and incubated at 37 C for 18-24 hr. A loopful of these -freshly 
g£own cells was then inoculated into a starter flask. The 
medium for the starter cultures was 100 ml of 2% (W/V) Vitamin-
free Casitone {Difeo), which was dispensed into 250 ml 
Erlenmeyer flasks and sterilized at 121 c for 15 min prior to 
inoculation. Once inoculated, these flasks were incubated for 
6 to 8 hr at 37 C on a rotary shaker. The use of freshly grown 
-obtain growth of the culture in the medium within this time 
period. 
The growth medium was inoculated with 1 ml of inoculum 
from the starter culture medium (Vitamin-free Casitone). The 
flasks were then incubated for 17 hr at 37 C on a rotary 
shaker {New Brunswick Scientific Co., New Brunswick, N.J.) 
at 240 rev/min. The cells were harvested, usually near the 
end of the log phase (17 hr) by centrifugation at 4 C in 
250 ml centrifuge bottles (IEC} at 30,000 x g for 15 min. 
The cell pellet was collected, washed twice with 0.8% saline 
and then used for the experiments. 
L . . 
To inoculate the synthetic medium, the cells from the 
starter culture medium were first centrifuged at 30,000 x 
27 
g for 10 min, washed twice with sterile 0.8% saline, adjusted 
to the standard optical density, 1500 Klett units; (a 1:10 
dilution reads 150 Klett units) and then one ml was transferred 
to the synthetic medium. The flasks were then incubated for 17 
hr at 37 C. 
Growth measurements. Growth was determined by measuring 
the turbidity of the culture in nephelometer flasks with a 
Klett-Summerson Colorimeter provided with a 600 nm filter. 
Sterile Vitamin-free Casitone or.synthetic medium w;::ic:: nc::p(l ;::ac:: 
a blank. The nephelometer flasks were 300 ml Erlenmeyer flasks 
with a side arm tube attached to the flask. The flask did not 
contain more than 100 ml of the medium and were exclusively 
used for the measurement of growth. The turbidity measurements 
were performed rapidly so as to provide minimum exposure of 
the cells to environmental changes. All the experiments were 
run in duplicate flasks and the values are the average of two 
separate experiments. When the difference in turbidity 
readings between duplicate samples was greater than 25%, the 
results of the experiment were rejected. 
L 
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Vitamin contents of the media. 2% Vitamin-free Casitone 
medium contained following concentrations of niacin and 
thiamine, based on information provided to us by Difeo 
Laboratories: 
Niacin....... 0.013 µg/ml 
Thiamine .•••• <0.00013 µg/ml 
Determination of glucose catabolic pathways. 
a. Radioisotope experiment. At the end of 17 hr 
of incubation the cells were harvested by centrifugation at 
30,000 x g for 10 min at 4 C, washed twice and suspended in 
was then adjusted with buffer to the same turbidity (180 
Klett units using a 1:10 dilution) using a 600 nm filter. 
A 1:10 dilution of this.heavy cell susoension that gave a 
reading of 180 Klett units was approximately equal to 3 mg 
dry weight/ml, an amount which was sufficient for the 
experiments. 
Metabolic flasks inoculation. Radioisotope experiments 
using labelled glucose were performed according to the method 
described by Goldman and Blumenthal (35). Erlenmeyer flasks 
(SO ml) fitted with a center well (metabolic flask) were used 
throughout the experiments. The center well was capable of l holding a small vial which contained a pa?erwick and also kept 
• 
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the vial isolated from the surrounding medium. 
Employing a 1 ml long tip pipet, 0.5 ml of 0.5 M glucose-
1-14c was added to the main comoartrnent of each of the two 
flasks. Similarly, glucose-6-14c of same concentration (O.S M) 
was added to the two additional flasks. One ml of 0.1 ~ 
(pH 7.0) potassium phosphate buffer was then added to the main 
compartment of all flasks using a 5 ml long tip pipet. For 
each metabolic flask in the experiment; two serological tubes 
were prepared containing 2.5 ml of 10% (V/V) perchloric acid. 
These were used for quantitative determination of glucose in 
the supernatant fluid. Using a 10 ml pipet, 2.5 ml of the 
-of each of the series of flasks at one min intervals. During 
each one min interval zero hour samples were removed for 
glucose as follows: the glucose-bacterial suspension in the 
flask was well mixed for 10 to 15 sec, and then a 0.5 ml sa~ole 
was removed using a separate 1 ml long tip pipet for each 
flask, and added to a serological tube containing perchloric 
acid. Following the removal of the zero hour sample, a small 
glass vial containing a folded piece of Whatman No. 1 filter 
paper (to increase co2 absorption) was added to the center 
well using a forcep. Each flask was immediately sealed with a 
ser-um stopper and was incubated in a Dubnof f metabolic shaKer 
L 
at 37 c. The flasks were shaken at about 100 cycles/min 
for 120 min. 
After all of the flasks had been started, a 1 ml 
'syringe with a long 22 gauge needle was used to inoculate 
30 
1 ml of the C02 absorbing solution into each vial previously 
p-laced in the center well. This s.olution consisted of 
~· "e~hanoJ.amine ethylene glycol monomethylether of the 
.fo-1-lowing composition (51): ethanolamine - ethyleneglycol 
:mon0methylether (1 :2 V/V). 
l..iqu.id scintillation counting of 14co2. When the in-
~- :cubat.i:on period was over, the flasks were removed from the 
:r ~·. 
~ker in the same order as they were put into the water 
~n. :Ylben the flask was removed, the serum stopper was 
::t'a..en nf:f, and the entire center well vial with its con-
-:E-~:tt-s f:t:rapped co2 , co2 absorbing solution and the paper) 
~;~ carefull7 added to a 20 ml scintillation vial, of low 
·-;::-~':::l:~~:..iJlm ~ontent (Packard Instrument Co.) • At the srune 
· · ,_. · S nl 'Jf sample from the main compartment of the 
·.c~-::~·~~~l -'.~ J'~oved for analysis of glucose remaining in the 
• 
•· · · ~::-. • ~1 r:.lj tJr]ded to the second serological tube containing 
~~intillation vial, containing a center vial, 
~ < '"'1 I f 
. r. 
1 I Ml of a mixture of toluene, ethylene-
.. 
glycolmonomethylether, 2,5-diphenyloxazole (PPO) (1:2:0.181 
V/V/W} as scintillator and 1 ml of ethanolamine-ethylenegly-
col monomthylether. A background scintillation vial was 
included in the experiments which consisted of non-incubated 
center well vial with a filter paper and a scintillation 
mixture of the same composition which was used to count the 
samples. Plastic screw caps lined with tin foil were then 
carefully placed on the scintillation vial. All of the 
vials were well mixed, cleaned on the outside, and then 
placed in Packard Tricarb Scintillation Spectrometer Model 
# 3320, for counting. All the vials, which were cooled 
for 6 to 8 hr before the counting started, were counted at 
least 3 -times. The system had a counting efficiency of 
approximately 80% for 14c. 
Determination~of·glucose utilization. The serological 
tubes containing bacterial-glucose suspension were centri-
fuged at 30,000 X g for 15 min. Following the removal of 
bacterial cells, glucose was determined by the anthrone 
method of Seifter et al. ( 106). 
b. Estimation of the pathways of glucose 
catabolism. The pathways of glucose catabolism were esti-
mated using the basic mathematical formulae devised by 
Wang et al. (119) and as modified slightly by Blumenthal 
( 5) • 
L 
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From the information of the amount of radioactive 14co2 
yield from glucose-1-14c and -6-14c along with the quantity 
of glucose (-1-C and -6-C) metabolized, determined by the 
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anthrone method, the percentage of HMP and EM were calculated 
using the following formulae. The percentage of 14co2 
yielded by glucose-6-14c is a rough estimation of the ex-
tent of the operation of the TCA cycle. 
HMP = 
where G1 = 
,.. 
-o 
= 
%EM = 
x 100 
GT 
14co 2 coming from glucose-1-+4c (cpm) 
11,- .~ irom , " \..V2 COlll.J..fl.9 glu~ose-o- - '- \ '-!;'lll i 
Total amount of glucose labelled 
utilized by cells during incubation. 
100 - %HMP 
Phosphate buffer-glucose medium. In order to study the 
effects of niacin or niacin analogs under resting cell con-
ditions, buffered glucose medium, devoid of any nitrogen 
source, was prepared by dissolving glucose in 0.05 M potas-
sium phosphate buffer, pH 7.0, to yield e final concen-
tration of 50 µmoles/ml. The medium was sterilized by 
autoclaving at 121 C for 10 min. Niacin, thiamine or 
niacin analogs were added to this medium under aseptic 
conditions. Washed cells, previously grown in Vitamin-free 
r ~. 33 
casitone (VFC) or VFC containing niacin or niacin and thiamine 
were inoculated in this medium and incubated at 37 C for 2 to 
3 hr. The incubated cells were then used either for isotope 
experiment or for enzyme analyses. 
Enzyme analyses of s. aureus. 
a. Preparation of cells for enzyme extraction. 
Levels of glucose-6-phosphate dehydrogenase (G6PD), 6-pho-
sphogluconate dehydrogenase (6PGD) and of other enzymes from 
the HMP pathway and the level of isocitrate dehydrogenase 
(ICD) from-the TCA cycle, were investigated. Staphylococcal 
cells were grown in Vitamin-free Casitone or in synthetic 
medium alone or in the presence of the vitamjns. All cultures 
- phase, ordinarily 17 hr. This period of growth was necessary 
because high cell densities were needed in order to obtain 
sufficient amounts of cells. 
At the end of the growth period, the staphylococci 
were harvested by centrifugation at 30,000 x g for 15 min 
using a refrigerated centrifuge (International Equipment 
Co., Model B-20) at 4 c. The supernatant fluid was care-
• 
fully discarded and the cells were then washed twice with 
0.8% saline. The cell pellet (ca. 1 g weight ) was then 
suspended in approximately four volumes of 0.01 M tris 
(hydroxymethyl)-aminomethane (tris) buffer, pH 7.5, con-
taining 0.0001 M EDTA (ethylenediamine tetraacetic acid). 
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The suspension was vigorously mixed with a vortex mixer ~nd 
then subjected to sonic treatment in a 10 Kc Branson Sonic 
oscillator (Model S-75) as follows. A 3.8-cm (diameter) 
solid step horn terminating in a 1.3-cm (diameter) irradiating 
area (stainless steel) attached to 500 ml water jacketed 
chamber was used for sonication of the cells. The cell sus-
pension was cooled to 4 C prior to the treatment and was 
subjected to sonic treatment for a total of 15 to 20 min. 
The sonication was performed intermittently, never more than 
40-50 sec at a time, and was followed by a 1-2 min period of 
cooling in order to prevent a rise in temperature and loss 
of enzymatic activity. During the treatment time cooling 
water (-10 C) was circulated through the jacketed chamber. 
Treatment times longer than 20 min tend to result in loss 
of enzyme activity of the extracts. Sonic treatment of 17 
min was found to be optimum for breakage of the staphylo-
coccal cells. 
After sonic treatment the mixture was centrifuged at 
30,000 x g for 20 min at 4 C. The supernatant fluid was 
carefully decanted into a test tube, which was stored in an 
ice bucket, and then used for the enzyme assay. 
Before enzyme analysis, the protein concentration in the 
crude extract was determined by the method of Waddell (118). 
This procedure of protein determination which depends on 
the absorption of peptide bonds at 215 and 225 nm, has a 
--
greater sensitivity than the other methods and eliminates 
the need for the addition of any reagents for color develop-
ment. 
b. Protein determination. A 0.02 to 0.04 ml 
sarnole of crude extract was added to a quartz cuvette and 
deionized distilled water was added to yield a final volume 
of 1.5 ml. The blank cuvette contained deionized distilled 
water. Absorbancy was recorded at 215 and 225 nm and the 
difference of optical density (OD) was multiplied by the 
factor of 144 and by the dilution factor. This yielded the 
final protein concentration in µg/ml of enzyme extract. 
l- , I '·, ' 1 , .: .. : •• • ~.· ' ·; 
The crude extracts were stored at -15 C and showed very 
little loss of activity of the enzymes studied, even after 
storage for several months. 
Reagents for the enzy:ne assay. All the solutions were 
made using doubly distilled, deionized water. 
L 
1. 
2. 
3. 
NADP solution (3 µmoles/ml) 
Dissolve 4.6 mg of NADP powder in 2 ml water 
NAD solution (3 µmoles/ml) 
Dissolve 4.0 mg of NAD powder in 2 ml water 
Tris-HCl buffer (75 µmoles/ml) 
Dissolve 0.09075 g of Tris (hydroxymethyl-aminomethane) 
in 100 ml of water. Adjust the pH to 7.5 with 1 N HCl. 
4. Manganese sulfate (30 µmoles/ml) 
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Dissolve 0.830 g of Mnso4 , H2o in water and make up . 
100 ml. 
5. Isocitrate (30 µmoles/ml) 
Dissolve 7,75 mg of d-isocitrate-Na2 in 1 ml water. 
6. Glucose-6-phosphate (30 µmoles/ml) 
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Dissolve 15.6 mg of glucose-6-phosphate-Na2 in 2 ml water. 
7. 6-Phosphogluconate (30 µmoles/ml) 
Dissolve 20.5 mg of 6-phosphogluconate-Na2 in 2 ml water. 
8. NADH solution (1 µmole/ml) 
Dissolve 3.4 mg in 5 ml 0.01 M Tris buffer, pH 8.0. NADH 
solution should be kept for no more than one week becaase 
of the possible formation of an inhibitory factor. 
9. NADPH solution (1 µmole/ml) 
Dissolve 4.2 mg in 5 ml of 0.01 m Tris buffer, pH 8.0. 
Keep for no more than one week. 
10. KCN solution 
Dissolve 1.3 mg in 10 ml water. 
11. AcPyAD solution 
Dissolve 12.5 mg in 1 ml water. 
12. Glucose-6-phosphate dehydrogenase, (G6PD) (1 mg protein/ 
ml) 
Dilute the stock solution with 2.2 M ammonium sulfate 
solution. 
37 
13. Isocitrate dehydrogenase (ICD) (1 mg protein/ml) 
Dilute the stock solution with 2.2 M ammonium sulfate 
solution. 
Enzyme assays. All the enzyme assays were performed at 
25 Con Gilford spectrophotometer, model 2000 (Gilford In-
strurnent Laborat0ry, Oberlin, Ohio.) equipped with auto-
matic recorder. Standard 1.5 ml and 3.0 ml cuvettes (quartz) 
with 1.0 cm light path were used. Enzyme assays were 
performed as described by Ragland et al. (96). 
a. Assay for isocitrate dehydrogenase.· The assay 
of isocitrate dehydrogenase was based on the reduction of 
Isocitrate --------------+ a-ketoglutarate 
NADP NADPH 
To a 1.5 ml cuvette the following solutions were added: Tris 
buffer 75 µmoles, Mnso4 1.5 µmoles, isocitrate 3 µmoles, 
deionized water 0.25 ml, extract 0.05 ml. After the deter-
mination of initial absorbance (at 340 nm), the reaction was 
started by adding 0.15 µmoles of NADP and was followed by 
recording absorbancy at 340 nm at 30 sec interval. The 
blank cuvette contained all the ingredients except NADP, 
which was replaced by distilled water. 
b. Assay for glucose-6-phosphate dehydrogenase. 
glucose-6-phosphate 
NADP 
-------~ 6-phosphogluconate 
NADPH 
The conditions for the assay of G6PD were the same as those 
for ICD, except that isocitrate was replaced by glucose-6-
phosphate (3 µmoles/0.1 ml). 
c. Assay for 6-phosphogluconate dehydrogenase. 
6-phosphogluconate 
NADP 
--------~ ribulose-5-P + C02 
NADPH 
The conditions for the assay of G6PD were the same as those 
for ICD, except that isocitrate was replaced by 6-phospho-
gluconate (3 µmoles/0.1 ml). 
d. Assay for transhydrogenase. The transhydro-
genase assay was based on the reduction of AcPyAD. 
NADPH + AcPyAD NADP + AcPyADH 
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To a 1.5 ml cuvette the following solutions were added: 
K2HOP4, 75 µmoles; NADPH2 , 0.45 µmoles; KCN, 1.5 µmole; 
distilled water, 0.30 ml; and crude extract 0.05 ml. After 
the determination of the initial absorbance, the reaction 
was started by addition of 0. 9 µmoles of_ AcPyAD and was 
followed by recording at 30 sec intervals the absorbance 
at 375 nm. The blank cuvette contained all ingredients 
except AcPyAD, which was replaced by distilled water. 
e. Assay for NADH and NADPH oxidase. To a 1.5 ml 
cuvette the following solutions were added: K2HP04 , 75 
µmole.s; NADH or NADPH, 0. 05 µmoles; and distilled water, 
0.4 ml. The reaction was started by adding 0.05 ml of 
extract and was followed by observing the decrease in 
absorbance at 340 nm. 
Calculations. All specific activities are expressed 
as nanomoles of coenzyme reduced/mg of protein/min. 
bE x v 
Specific activity = 
10-6 x exd x mg of protein 
in reaction mixture. 
bE = change in absorbance/min. 
V = volume of the reaction mixture in the cuvette. 
E = .f!.xtinction ("'!()Pffj Ci Pnt Of thP "j l nht" 3~~nrhi l'HT cmt)-
Stance. (cm2/µmole) for NAD (340 nm) •. 6.22 x lOb 
for AcPyAD (375 nm) •• 5.2 x 106 
d = light path of cuvette (1 cm). 
Uptake of niacin and its analogs. 
a. Preparation of staphylococcal cells for uptake 
studies. Staphylococci previously grown in unsupplemented 
Vitamin-free Casitone were harvested by centrifugation, as 
described previously. These cells were washed three times 
• 
with sterile saline (0.09%) and then suspended in 0.01 M 
potassium phosphate buffer (pH, 7.0) to yield a cell sus-
pension of known concentration. The concentration of the 
cells was adjusted to a turbidity of 1500 Klett units 
\ 
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(150 Klett units on a 1:10 dilution) using distilled water 
as a blank. 
b. Measurement of uptake of niacin and niacin 
analogs. The incubation medium for the uptake studies was 
of the following composition: 
Potassium phosphate buffer, pH 7.0, 0.1 M .• 1.-0 ml 
Glucose ( 1 % ) •••••• ~ • • • • • • • • • • • • • • • • • • • • • • • • 0. 5 ml. 
Niacin or niacin analog (cone. variable) ..• 1.0 ml 
Washed cells . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2. 5 ml 
The cell suspensions and the reaction mixture were 
equilibrated at 37 C before mixing. The reaction was started 
by the addition of labelled niacin or labelled niacin analog. 
Unless otherwise stated, the flasks were incubated at 37 C 
- ~ 1.1 ... - -· - , ., -· ,.. -, ! I 'I 
the medium. All incubations were carried out in duplicate and 
the experiments were repeated at least once. The concentrations 
of niacin, quinolinic acid and of isoniazid that were used, are 
listed in the respective tables of the results section. 
The flasks were incubated for various intervals of time. 
When the incubation had been completed, 0.2 ml samples were 
rapidly withdrawn and filtered on membrane filters (0.45 µ 
pore size) that had been previously saturated with the 
appropriate unlabelled substrate. The cells which were 
retained by the filter were quickly washed twice with 1 ml 
deionized distilled water. The filtrate and the membrane 
filter containing the cells were added to separate 20 ml 
--
scintillation mixture to each vial, they were counted in a 
liquid scintillation spectrometer. When the difference in 
counts between duplicate samples was greater than 25%, the 
results of the experiment were rejected. 
The scintillation mixture used for counting radio--
a=tivity in the cells and in the filtrate was of following 
composition: p-dioxane, 900 ml; anisole, 150 ml; 1,2-
dimethoxyethane, 150 ml; PPO, 18g; and POPOP, 60 mg. 
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Among the factors that were included in the permeability 
studies were the effects of time, temperature, pH and energy 
source, competition between niacin and its analogs, and the 
rat.e or f>"<'Ch<=maP of. ·1 <"I tie l ! Pd n1 ;:,r.i:n, 
c. Competition studies between niacin- and its 
analogs. Competition studies between niacin and its analogs 
were performed using radioactive niacin and either unlabelled 
niacin or unlabelled analog. The concentration of unlabelled 
niacin or unlabelled analog (pyridine-N-oxide, isoniazid, 
quinolinic acid, or 3-pyridylcarbinol) added to the in-
cubation mixture, was 1000-fold higher than the concentration 
of labelled niacin. The reaction was carried out for 1 hr 
period after which 0.2 ml of samples were withdrawn for the 
estimation of radioactivity within the cells and in the 
supernatant fluid. 
d. Measurement of exchange between intra- and· 
extracellular niacin and its analogs. In the experiment 
involving exchange between accumulated radioactive niacin 
and extracellular unlabelled niacin or the analogs, 
staphylococcal cells were incubated in reaction mixture 
containing niacin (2 µg/mJ), as described previously, for 
60 min at 37 c. During this incubation period the niacin 
binding sites became saturated. These niacin loaded cells 
were collected by centrifugation at 30,000 xg for 15 min at 
4 C. They were washed twice with sterile 0.8% saline and 
suspended in 0.05 M phosphate buffer, (pH 7.0). The cell 
described previously. Exchange reactions were initiated 
by adding standardized cell suspension to incubation medium 
from which labelled niacin was omitted and to which un-
. . 
labelled niacin (2 mg/ml) or one of the analogs (2 mg/ml) 
was added. After the desired intervals of time, samples 
were removed and cellular radioactivity was determined. 
Chemicals 
Chemicals and enzymes. The chemica~s and enzymes were 
obtained from commercial sources and were not further 
purified. S-NAD (yeast), NADP (from yeast NAD), S-NADH 
(grade III, yeast), NADPH (type III), AcPyAD (type I), 
glucose-6-phosphate dehydrogenase (Zwischenfement, type V), 
isocitrate dehydrogenase (type IV), chloramphenicol and 
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puromycin were purchased from Sigma Chemical Co., St. Louis, 
Mo. The disodium salts of glucose-6-phosphate and isocitrate 
were obtained from C. F. Boehringer, Mannheim, Germany. 
Thiamine hydrochloride was obtained from J. T. Baker Chemical 
Co., Phillipsburg, N.J., and niacin (nicotinic acid) from 
Merck and Co., Rahway, N.J. Anthrone was a product of 
Nutritional Biochemical Corp., Cleveland, Ohio., and 
actinomycin D was purchased from Mann Research Laboratories, 
N.Y. All other chemicals were reagent grade. 
Chemicals for scintillation mixtures. PPO (2,5-
diphenyloxazole}, anisole, 1,2-dimethoxyethane and ethanol 
amine·were purchased from Eastman Organic Chemicals, Rochester 
N. Y.. Ethy ler.u:9 lycol1uu.1.10nu:: t..hy le Lht:.1.. a.11d l:J-<l.i.o:Aa.wi: wc:i. i:: u1.r 
t.ained from Fisher Scientific Co., Fairlawn, N.J-. POPOP (1, 
4-bis-(2-(5-phynyloxazolyl))-benzene was purchased from 
Packard Instrument Co., Downers Grove, Ill. 
Niacin analogs. Nicotinuric acid, pyridine-3-sulfonic 
acid and picolinic acid were obtained from Nutritional 
Biochemical Co., Cleveland, Ohio. The halogenated deriva-
tives of niacin, 5-fluoro-, and 5-chloronicotinic acid, and 
5-fluoronicotinamide were gifts from Dr. F. Streightoff, Eli 
Lily Co., Indianapolis, Ind. Hydroxylated derivatives of 
niacin, 2-hydroxy, 4-hydroxy and 5-hydroxyniacin were kindly 
provided by Dr. O. N. Miller of Hoffman-La Roche, Nutley, 
N.J. All other niacin analogs were purchased from Aldrich 
Chemical Co., Milwaukee, Wisconsin. 
Radiochemicals. Niacin-7-14c was purchased from 
Nuclear Chicago Corp., Des Plaines, Illinois, and had a 
specific activity of 27.9 mCi/rnM. Quinolinate-14c and 
isoniazid-14c were purchased from G. D. Searle and Co., 
Des Plaines, Illinois, and had a specific activity of 
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43.7 mCi/rnM and 9.85 mCi/rnM, respectively. Glucose labelled 
on -6-14c and -1-14c were obtained from Volk Radiochemical 
Co., Des Plaines, Illinois. 
• 
III. RESULTS 
A. Growth of S. aureu~ in Vitamin-free Casitone. 
S. aureus requires niacin for growth, and both niacin 
and thiamine are necessary for maximum growth stimulation. 
A typical growth curve of S. aureus strain Towler, in 2% 
Vitamin-free Casitone medium is shown in Fig. 1. This 
medium was chosen for the present studies because it contains 
very low amounts of niacin and thiamine. 
The results of the growth curve (Fig. 1) demonstrated 
that there was only a moderate growth of staphylococci (i.e., 
72 Klett units) in the absence of any exogenous addition of 
-traces of vitamins present in the medium. The amounts of 
vitamins present in 2% Vitamin-free Casitone are as follows: 
0.013 µg/ml of niacin, and <0.00013 µg/ml of the thiamine 
(Personal communication, Difeo Laboratories). Addition of 
thiamine (2 µg/ml) to the growth medium increased the amount 
of growth only slightly above that in an unsup?lemented 
control. The addition of 2 µg/ml of niacin, however, in-
creased the turbidity readings from 72 to 250 Klett units 
(24 hr). This stimulation indicated that niacin was present 
in limited concentrations for growth in the unsupplemented 
growth medium. Supplementation with both niacin and 
thiamine resulted in maximal increase of the growth rate. 
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Figure 1. Growth of S. aureus Towler, in 2% Vitamin-
free Casitone with or without suoplementary 
n1ac1n(2 ug/ml) ana/or thiamine(2 ~g/ml). 
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The growth, on rotary shaker at 37 C, was 
followed by measuring the turbidity at 600 nn1. 
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After 24 hr of incubation, the turbidity measurement reached 
a maximum of 336 Klett units, as compared to 72 Klett units 
in the unsupplemented Vitamin-free Casitone. These results 
demonstrated necessity for the presence of both vitamins for 
maximal stimulation of staphylococcal growth. 
B. Analyses of the glucose catabolic pathways and of 
enzyme levels. 
(1) Glucose catabolism in Vitamin-free Casitone 
and in synthetic medium. 
Table 1 shows the result of isotopic experiments 
when vitamin supplements were added to a coagulase positive 
.::.:lreu.:: strain Tm1lcr, · grown in 2~ TT.! ..L. --~ ,.,.. .C"'t-- r."\ 
-·----··--- _..;_,_,_ 
Casitone and in synthetic medium. The results demonstrated 
that staphylococci grown in unsupplemented 2% Vitamin-free 
Casitone had a very low metabolic rate and a markedly 
decreased utilization of the HMP pathway. Approximately 5% 
of the glucose was catabolized via the HMP pathway, while 
the relative activity of the TCA cycle was less than 1%. 
Addition of thiamine alone to the growth medium did not 
stimulate the HMP cycle and resulted in only a small in-
crease in the TCA cycle activity. When the cells were grown 
in a niacin-supplemented medium, however, they exhibited a 
3- to 4-fold increase in the HMP pathway (i.e., from 5 to 
22%) with a slight stimulation of the TCA cycle activity. 
Supplementation with vitamins resulted in a 3-fold increase 
TABLE 1 
Effect of niacin and thiamine on the glucose catabolic 
pathways of Stanhylococcus aureus strain Towler 
Addition (µg/ml) to % Glucosea 
2% Vitamin-free Casi tone catabolized via TCA cycle 
EM HMP activity (%) 
None 95.0 5.0 0.9 
Thiamine (2) 94.8 5.2 1.2 
Niacin (2) 78.0 22.0 1.0 
l.:rj :1("5 n {?) -!- r:r'h:i.nrr.4~~f? (., ' 82. (' 1 g. (' -1 • c: \<f. • 
Addition (µg/ml) to 
synthetic medium 
Niacin (8) 67.0 33.0 2.0 
Niacin ( 8) + Thiamine ( 4) 65.0 35.0 4.0 
a Glucose catabolic pathways (EM and HMP) and the TCA cycle 
activity were determined by the yield of 14co2 from 
glucose-!- and -6-14c. 
The values are the average of at least 3· determinations. 
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Figure 2. Glucose utilization by s. aureus. Staphylococcal 
cells were first grown in 2% Vitamin-free Casitone 
with or without supplementary niacin, 2 µg/rnl, 
and/or thiamine, 2 µg/ml. The utilization of 
glucose was determined under ~esting cell conditions 
at indicated time by the method of Seifter et al .. 
(106). 
r . . ~ 50 
in utilization of the HMP pathway and a 5-fold increase in 
the activity of the TCA cycle. For instance, the amounts of 
glucose catabolized via the HMP pathway and the relative 
activity of the TCA cycle were 18% and 4.5%, respectively. 
These experiments indicated that niacin was 
required for stimulation of the HMP pathway, while both 
niacin and thiamine were necessary for the maximal operation 
of the TCA cycle. Increasing the concentration of the 
vitamin in the medium from 2 to 10 µg/ml did not result in 
any additional changes in the degree of utilization of the 
different glycolytic pathways. 
Htsult.& of E:Xpt:riments with cells grown l.Il syn-
- thetic media were more or less similar to the results 
obtained with cells grown in Vitamin-free Casitone. Since 
staphylococci were unable to grow in synthetic media lacking 
niacin, the isotope experiments were not done. The amount 
of glucose catabolized via the HMP pathway was approximately 
30-35% in cells grown in the synthetic medium compared to 
18-20% in cells grown in supplemented Vitamin-free Casitone. 
The TCA cycle activity in the synthetic medium was increased 
{2%), even in the absence of added thiamine. However, 
addition of thiamine to the niacin-containing synthetic 
medium resulted in a 2-fold increase (4%) in the TCA cycle 
activity. This indicated that greater quantities of 
thiamine were needed for maximal operation of the TCA cycle 
than were needed for the maximal operation of the HMP path-
way. 
(2) Enzyme levels of the glycolytic pathways of 
staphylococci previously grown in Vitamin-free Casitone and 
in synthetic medium with or without vitamin suoplementation. 
The growth of S. aureus was relatively poor in 
unsupplemented Vitamin-free Casitone, and the relative 
activities of the HMP pathway and the TCA cycle were also 
low. The addition of niacin or niacin and thiamine to the 
growth medium not only stimulated growth maximally (Fig.l) 
!.ru.~ ..:1.lLo inc:i::E::c..~e;:d act.iviLi~.s of the HMI' and Lllc. TCl~ c~-.:.:: 
_by 4-fold (Table 1). Analyses of some key enzymes of the 
HMP pathway and of the TCA cycle under various conditions of 
growth in both Vitamin-free Casitone and in synthetic media 
were undertaken in an attempt to determine. if the increased 
activities of the pathways were due to increased enzyme 
synthesis. 
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When S. aureus was grown in Vitamin-free Casitone 
medium (Table 2), the specific activities of G6PD ranged from 
40 to 50 nmoles/mg protein/min, while the activity of 6PGD 
and ICD varied between 15 to 25 nmoles/mg protein/min. The 
addition of thiamine alone resulted in only a slight increase 
in ICD activity (from 15 to 21 units), while the activities 
of G6PD, 6PGD and of other enzymes remained unaffected. 
TAEL ~ 2 
Specific activities of enzymes fr Jn extracts of s. aureus grown in 
Growth Medium 
Vitamin-free Casitone 
Vitamin-free Casitone 
+ niacin (2 µg/ml} 
Vitamin-free Casi tone 
+ thiamine (2 µg/ml) 
Vitamin-free Casi tone 
+ niacin and thiamine 
Synthetic medium + 
niacin (8 µg/ml) 
Synthetic medium + 
niacin (8 µg/ml) and 
thiamine (4 µg/ml) 
Enzyme activities were 
variot:; media 
Specific actii/~ty of enzyme, nmoles/mg protein/min 
Glucose-6-
P-dehydro-
genase 
49 
161 
(20.5a) 
48 
( 0. 2) 
153 
(13. 7) 
75 
(3.1) 
98 
( 5. 5) 
determined 
6-Phospho-
gl uconate 
de hydrogen :ue 
23 
37 
( 2. 0} 
20 
(0.5) 
39 
( 2. 7) 
20 
( 0. 36) 
30 
(1.17) 
by the mett :J :I. of 
Isocitrate-
dehydrogen-
ase 
15 
22 
(1.16) 
21 
(0.8) 
49 
( 5. 6) 
16 
(0.14) 
28 
(2 .1) 
Ragland et 
Transhy- NADPH 
drogen- oxidase 
ase 
12 3 
14 6 
( 0. 3) (0.6) 
7 3 
(0.6) (O.O) 
9· 8 
( 0. 35) ( 0. 9) 
3 3 
(1. 6) (. 0) 
8 5 
(0.57} (0.63) 
al. ( 9 6) • 
NADH 
oxidase 
12 
25 
(1. 4) 
16 
( 0. 5) 
19 
(0.7) 
11 
(0.13) 
5 
( 1. 8} 
a Difference of mean by "t" test~ a value of 2.0 or greater is significant at the 5% level 
or better. ~ 
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Following growth stimulation brought about by the addition 
of niacin to the growth medium, however, there was a 3- to 
4-fold increase in the specif~c activity of G6PD (from 49 
to 161 units), with some increases in 6PGD, !CD and TH levels. 
For instance, the specific activities·of 6PGD, !CD and TH in 
niacin-grown cells were 37, 22 and 14 nmoles/mg protein/min, 
respectively. The NADH oxidase activity was elevated by 
2-fold. Similarly, addition of niacin and thiamine not only 
stimulated G6PD synthesis but also increased ICD activity 
from 15 to 49 nmoles/mg protein/min. Generaillyr, the 
activities of transhydrogenase, NADH oxidase and NADPH 
The specific activities of G6PD, 6PGD and ICD in 
supplemented 2% Vitamin-free Casitone was 153, 39 and 49 
nmoles/mg protein/min,respectively, while in synthetic 
medium it was 98, 30 and 28 nmoles/mg protein/min, respec-
tively (Table 2). Although there was 30 to 50% reduction 
in the specific enzyme activities when the staphylococci 
were grown in synthetic medium, the operation of the HMP 
pathway in these cells was higher than in the cells grown in 
supplemented Vitamin-free Casitone. 
(3) Glucose catabolic oathways and levels of some 
dehydrogenases of different strains of S. aureus grown in 
supplemented Vitamin-free Casitone. In order to show that 
the observation made on the Towler strain of S. aureus was 
TABL~ 3 
Uniformity in effect of niacin and thiamine on the glucose catabolic pathways and on 
some dehydrogenases of staphyloco~~i grown in Vitamin-free Casitone 
Turbidity Glucose-6-Pa 6-P-glu:n- Isocitrate 
(17 hr), de hydro- nate det1 l- de hydro-
HMPb 
TCA cycleC 
Strain Klett units genase drogena:; ·~ genase % activity 
Towler 340 153 39 49 18.1 5.2 
18 z 310 149 32 51 18.5 4.3 
23 331 160 28 44 .\ 9. 3 4.6 
a Specific activities are expressed as nanomoles/mg protein/min 
b % glucose catabolized via the HMP pathway a> determined by the yield of 14co2 from glucose-1- and -6-14c. 
c Re la ti ve activity" of the TCA cycle as dete"::".'·lined by the yield of 14co2 from 
glucose-6-14c. 
r 
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not p~culi~r to that strain alone, the glucose catabolic 
pathways and the specific activities of G6PD and 6PDG from 
the HMP pathway and of ICD from the TCA cycle were also 
measured in other coagulase positive strains of staphylo-
cocci previously grown in supplemented Vitamin-free Casitone. 
The results of these studies showed that the other coagulase 
positive strains followed the same pattern as strain Towler. 
For instance, addition of both vitamins to the growth medium 
not only resulted in maximum growth (310 to 340 Klett units) 
but also increased glucose utilization via the HMP pathway 
and the TCA cycle activity to 19% and 4.5%, ~espectively. 
tested were approximately 150, 32 and 45 nmoles/mg protein/ 
min, values similar to those obtained for the Towler strain. 
Addition of vitamins to the growth medium stimu-
lated growth maximally (340 Klett units) and increased the 
HMP and the TCA cycle activities to 20% and 5%,respectively. 
Along with the increases in the HMP pathway, the level of 
G6PD was also tripled. Thus there was a strong correlation 
4 
between the activities of the HMP enzymes and the degree of 
operation of the HMP pathway. 
(4) Glucose catabolic pathways and enzyme levels 
under resting cell conditions. The effect of vitamins on the 
glucose catabolic pathways was tested under resting cell 
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conditions and the results are shown in Table 4. The data 
from Table 4 (Expt.I) indicated that the incubation of 
vitamin-deficient resting cells in buffered glucose resulted 
in cells which oxidized glucose in a manner similar to that 
of cells grown in the presence of the vitamins. For instance, 
when vitamin-deficient cells were incubated with the vitamins, 
the amount of ~lucose catabolized via the HMP pathway and the 
relative activity of the TCA cycle were 18% and 5.6%, respec-
tively, values similar to those of cells grown in the 
presence of the vitamins. These results indicated that the 
vitamins stimulated these metabolic activities even in the 
absAncA ~r qrowtn. 
The results of the enzyme analyses under resting 
cell conditions are presented in Table 5. The levels of G6PD 
and 6PGD were not increased by the presence of niacin, even 
though the HMP pathway activity was increased. Similarly, 
ICD activity remained low when both vitamins were added to 
the medium. For example, the specific activities of G6PD 
and ICD were 43 and 15 nanomoles under resting cell conditions 
compared to 153 and 49 nanomoles/mg protein/min when the cells 
were grown in the presence of these vitamins. In spite of the 
low activities of G6PD and ICD (i.e., 43 and 15 units) under 
resting cell conditions, there was a greater utilization of 
glucose via both the HMP pathway and the TCA cycle. 
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TABLE 4 
Changes in the glucose catabolic pathways and in the TCA cycle 
activity in the absence of growth by incubation of vitamin-
deficient S. aureus Towler suspensions with thiamine and/or 
niacin 
Additions to the vit-
amin-deficient resting 
Expt. cell suspensiona 
1. 
2. 
3. 
4. 
None 
Thiamine, 4 µg/ml 
Niacin, 8 µg/ml 
Niacin and thiamine 
Niacin (2 µg/ml} and 
thiamine (2 µg/ml} 
Ni?~in ~nrl ~~ia~1np wi~h 
chloramphenicol 
c25 µg;in1> 
Niacin (2 µg/ml} and 
thiamine (2 µg/ml) 
Chloramphenicol 
(25 ·µg/ml}, plus niacin 
and thiamine 
Chloramohenicol (50 
µg/ml), plus niacin 
and thiamine 
None 
Chloramphenicol(50µg/ml} 
Chloramphenicol(lOO 
µg/ml}, plus niacin 
and thiamine 
TCA cycle 
activity 
( % } 
0.2 
1.2 
0.6 
5.6 
4.0 
] ' (l 
4.0 
4.0 
3.0 
0.6 
0.9 
4.0 
% Glucose 
catabolized via 
EM HMP 
92 
92 
79 
82 
80 
84 
84 
86 
83 
95 
95 
88 
8 
8 
21 
18 
20 
I f. 
16 
14 
17 
5 
5 
16 
a After growth for 17 hr in 2% Vitamin-free Casitone, the cells 
were washed with and suspended in 0.05 M Na and K phosphate 
buffer, pH 7.0, at twice their original concentration. 
Glucose was added at a concentration of 50 µmoles/ml, and 
the flasks were placed on a rotary shaker for 3 hr at 37 C. 
These cells were then harvested and used in the usual manner. 
TAF L !: 5 
Influence of the addition of vitamins, in the· ~bsence of growth, on some enzyme activities 
of vitamin-deficient EU3pensions of s. aureus 
-
Specific activiti~s of enzymes, nmoles/mg protein/min 
Addition to the Glucose-6-P 6-P-gJu:onate Isocitrate NADH NADPH 
vitamin-deficient dehydrogcnase dehyd1c~enase dehydrogenase oxidase oxidase 
s. aureus 
None 42 12 12 6 3 
Niacin (2 µg/ml) + 43 2C 15 8 5 
thiamine ( 2 µg/ml) (0 .19a) ( 0. 8) ( 0. 3) ( 0. 3) (0.47) 
Niacin + thiamine + 44 13 16 9 4 
chloramphenicol (50) ( 0. 32) (0.1) (0.57) (0.5) (0.34) 
Chloramphenicol ( 50) 40 ; c 17 10 5 
(0.6) co. e > (0.7) (0.56) (0.69) 
Cells· were grown in 2% Vitamin-free Casitone f~r 17 hr, washed with, and suspended in 
0.05 M Na and K phosphate buffer, pH 7.0, at t~ice their original concentration. 
Glucose was added at a concentration of 50 µ~;oles/ml and after the indicated additions 
were made the flasks were placed on a rotary Ehaker at 37 C for 3 hr. The cells were 
then washed and the enzyme activities were determined in the crude extracts by the 
method of Ragland et al. (96). 
a Difference of means by "t" .test; a value c.f 2.0 or more is signifi~ant at the 5% 
level or better. 
VI 
00 
(5) Changes in glucose catabolic pathways and.in 
enzyme levels by the addition of vitamins in the absence of 
protein synthesis. To insure that protein synthesis was not 
proceeding from the endogenous amino acid pool, vitamin-
deficient staphylococcal cells were incubated in a buffered 
glucose medium containing niacin and thiamine (2 µg/ml, 
each), and along with any of the following antibiotics: 
puromycin, chloramphenicol, or actinomycin D. 
The results of the experiments, presented in Table 
6, were essentially the same as those reported in Table 4, 
in that niacin and thiamine stimulated the HMP p·athway and 
the TCA cycle activity (ca. 1.8% and 4%) even in the presence 
of antibiotics. The chloramphenicol control experiment 
(Table 4, Expt. 4) in which the vitamins were omitted showed 
that the antibiotic itself was not responsible for any of 
the observed biochemical changes. In the presence of 
actinomycin D, over 30% of the glucose was catabolized via 
the HMP pathway, following the addition of vitamins, a value 
considerably higher than that reached in the absence of the 
antibiotic 
Analyses of enzyme activities again demonstrated · 
that (following the addition of the vitamins), the level of 
G6PD was not significantly increased over the control value 
(44 units, Table 5). The specific activities of the other 
enzymes also re~ained less and variable. 
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Effect of niacin and thiamine on some bioc:1cmical properties of vitamin-deficient 
s. aureus in the absence of protein synthesis 
Intact Cells· 
% Glucose via HMP 
Rel. act. of TCA 
Cell Extracts 
NAD, µmoles/g. 
dry wt. 
NADP, µmoles/g/ 
dry wt. 
Glucose-6-P dehydro-
genase, Sp. Act. 
Isocitrate de hydro-
genase, Sp. Act. 
Vitamin-deficient res~ing cellsa incu-
bated in buffered glur·~ose containing 
niacin + thiamine ( 5 ·:9/ml) and: 
Chloram- T'uro- Actino-
No phenicol, ~ycin, mycin D, 
antibiotic 25 µg/ml ~ µg/ml 3 µg/ml 
O Hr 3 Hr 
5.0 16.0 
0.6 4.0 
0.2 3.5 
0.2 0.4 
46.0 42.0 
22.0 13.0 
3 Hr 
14.0 
4.0 
3.8 
D.4 
42.0 
16,0 
3 Hr 
18.5 
5.7 
3.5 
0.5 
3 Hr 
34.0 
5.0 
13.2 
2.2 
Resting cellsb 
previously grown 
on Vitamin-sup-
plemented (5 µg/ml 
niacin + thiamine) 
medium 
16 .·o 
4.0 
6.7 
0.5 
145.0 
58.0 
a Cells were grown for 17 hr in unsupplemen;.:ed 2% Vitamin-fre~ Casitone, harvested, 
washed with saline, and suspended in 0.05. t! phosphate buffet, pH 7.0, containing 
0.9% glucose, niacin and thiamine. 
b Cells were grown for 17 hr in 2% Vitamin-·:ree Casitone containing niacin and 
thiamine, and suspended in 0. 05 M phospha-.:E buffer, pH 7. 0, with no vitamins. 
Since the addition of the vitamins under resting 
cell conditions did not significantly increase the specific 
activities of the enzymes tested, and since the use of anti-
biotics precluded protein synthesis, new enzyme synthesis 
as a possible explanation for the increased activity of the 
HMP pathway has been eliminated in the present studies. 
Parallel experiments in this laboratory have 
demonstrated that when the vitamin-deficient resting cells 
were incubated with antibiotics for 3 hr with either niacin 
or niacin and thiamine, the NAD and NADP levels increased 
10- and 2-fold, respectively (44). 
(6) Tl?-~ .. ~!-~~ct_ <?,~---~!-~EY:~tion on qlucose cata,bo~ic 
pathways of s. aureus. Results of the previous experiments 
(Table 4) indicate that increased enzyme levels were not 
responsible for the increased operation of the HMP pathway 
following ~ddition of niacin. Sine~ there were 10- and 
2-fold increases in the NAD and NAD~ levels, respectively, 
along with increased activity of the HMP cycle, it is likely 
that one of the coenzymes regulated the HMP pathway activity 
of S. aureus in some manner. Since the .NAD content in 
E. coli has been found to decrease during a period of 
incubation in buffered glucose (86), experiments were 
therefore designed to determine whether such a variation 
in NAD could be observed in staphylococci during starvation 
and, if so, to correlate the NAD and NADP levels with the 
61 
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degree of utilization of the EM and HMP pathways. 
Fig. 3 presents the results of the glucose catabolic 
pathways during starvation of staphylococcal cells previously 
grown in Vitamin-free Casitohe supplemented with 0.5 µg/ml 
of niacin and 2.0 µg/ml of thiamine. This niacin level was 
selected to yield cells with a high level of glucose oxidation 
via the HMP pathway, but with levels of NAD that we~~ not high. 
The results of nicotinamide coenzymes are included for the 
purpose of comparison (Fig. 3). 
During the 2 hr period of starvation the operation 
of the HMP pathway was reduced from 18.5% to 10%. Similarly, 
a 50% reduction in NAD content was observed (i.e., 2.3 to 
1. 2 micromoles/g dry weight). Throughout the incubation 
period the level "of NADP was not reduced and remai:neciover; 
•1- ... 
0.4 micromoles/g. There was no further decline in the HMP 
pathway as the incubation continued. The amount of glucose 
catabolized via the HMP cycle was approximately 9.8% after 
4 and 6 hr of starvation, compared to 18.5% before starvation. 
Further reduction in NAD content from 1.0 to 0.6 micromoles/g 
was noted, and this level remained unchanged as the in-
cubation continued. The level of NADP did not decrease but 
rather increased as the incubation period continued up to 
6 hr. Throughout the period of starvation the activity of 
TCA cycle decreased slightly but was still quite active. 
Thus, the TCA cycle activity at O, 2, 4 and 6 hr was 4.5, 
63 
24 2.4 
2.0 
20 
;_. 
i:z.::I f== 
....:i 
°' 
u 
>- \ 1 •. (l ;;.... 16 \ u \ :::::: 
\ p ~ \ I 
< \ I \ u \ 
, 
E-< I t.:> I \ I 1.2 ........ 12 \ p ,..... A \ ::i.. \ z \ 
---- Niacin//~ .._, < b.. ... ........ -< ... z ::i.. ::E: 8 ""O.__ I 0.8 ::i:: ------<:! ~ 
':"" '~ .Jiit r.- NADP , ,.,r··"" z UJ 
i:z.::I ta 
u . ·~·-·-·-·-..-· ....:i i:i::: 0.4 0 i:z.::I 4 --·-·-·-----· ~ ::i.. TCA • ...... • • ....... 
1 2 3 4 5 6 7 8 9 
TIME (HOUR) 
Figure 3. Biochemical changes in s. aureus during i~c~~ation 
in buffered glucose. Cells were gro~n for 17 hr 
in 2% Vitamin-free Casitone suoplemented ~i~h 
0. 25 µg/ml niacin and 4 µg/ml thiamine, '.·:as'.':ed 
with saline and incubated in 0.05 MK phos?hate 
buffer, pH 7.0, containing glucose. At intervals 
samples were removed for the analyses of glucose 
catabolic pathways in a manner previously 
described (see Methods). 
4.0, 3.8 and 3.0 percents, respectively. 
At the end of the 6 hr incubation period niacin 
(100 µg/ml) was added to the buffered glucose medium and the 
incubation was continued for another 2 hr. Following this 
procedure, the operation of the HMP pathway increased from 
10% to 19% while the NAD rontent was increased to 1.3 
µmoles/g dry weight. The NADP content also rose from 0.6 to 
0.7 µmoles/g. On the basis of these findings it is evident 
that for staphylococci, NAD levels above (approximately) 1.5 
µmoles/g were necessary for the operation of the HMP pathway 
at levels above 20%. 
r Stndiec ~ith nia~jn anaJoqs 
(1) Growth curve of s. aureus in Vitamin-free 
Casitone in the presence of niacin analogs. The results of 
preliminary studies on the effect of several niacin analogs 
on the growth of S. aureus, Towler, in Vitamin~free Casitone 
are presented in Fig. 4 and 5. In Vitamin-free Casitone 
(Fig. 4) the small amount of growth (turbidity of 70 Klett 
units) tripled upon the addition of niacin. When niacin was 
replaced by niacin analogs in concentrations ranging from 
100 to 1000 µg/ml, there was a moderate increase in growth. 
For instance, none of the analogs produced turbidity 
readings over 150 Klett units in 24 hr of incubation in 
comparison to the 250 Klett units produced in the presence 
of niacin. In the presence of thiamine (Fig. 5), however, 
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Figure 4. Growth of s. aureus in 2% Vitamin-free Casitone 
with added analogs of niacin. Experimental 
conditions were same as in Fig.l. N=niacin, 
2 µg/ml; NNO=nicotinamide-N-oxide, 100 ~g/~l; 
NDA=nicotinyldiethylamide, 100 µg/ml; 
3-AP=3-acetylpyridine, 1000 µg/ml; C=unsupple-
mented Vitamin-free Casitone. 
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Figure 5. Growth of S. aureus in 2% Vitamin-free 
Casitone with added nia~in analogs and 
thiamine. Experimental conditions were 
same as in Fig.l. The concentrations of 
niacin, thiamine and of niacin analogs 
were same as in Fig. 4. 
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all the analogs tested with the exception of 6-HN and 6-AN 
produced approximately the same stimulation as the addition 
of niacin and thiamine. For example, when nicotinamide-N-
oxide (NNO), thionicotinamide (ThN), or 3-acetylpyridine (3AP) 
were added to a thiamine supplemented growth medium, the 
turbidity measurement reached a maximum of 330 to 360 Klett 
units. 
Data from Fig. 4 and 5 indidated that the concen-
tration of niacin analogs required for the maximal stimulation 
·,~ 
of growth was approximately 100- to 1000-fold hi_gher than that 
of niacin. The use of 3-acetylpyridine or pyridine-3-sulfonic 
and Table 13). Necessary concentrations of other pyridine 
derivatives varied somewhat from 100 to 500 µg/ml in order 
to support full staphylococcal growth when added to the 
Vitamin-free Casitone medium with added thiamine. 
In addition, results of these growth curve studies 
demonstrated no lag in the growth in the presence of niacin 
analogs. The duration of the observed lag period was similar 
to that produced when niacin was added to the growth medium. 
This indicated that the growth-stimulating effect of the 
addition of analogs was not due to selection of mutants 
capable of using analogs. 
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(2) Growth of S. aureus in synthetic meditim in the 
presence of niacin analogs. Since Vitamin-free Casitone 
contains small and variable amounts of niacin and thiamine, 
the effect of the niacin analogs on S. aureus growth in 
completely synthetic medium was investigated. The results 
of these studies are presented in Table 7. The findings of 
these experiments showed practically no growth of staphylo-
cocci in the absence of either niacin or niacin and thi'arnine. 
A turbidity reading of 55 Klett units was obtained when 
niacin alone was present in the synthetic medium, while growth 
reached a turbidity of 270 Klett units {48 hr) when both 
niacin analogs in the medium lacking thiamine, g~owth varied 
somewhat from 11 to 40 Klett units. Data in Table 7 shows 
that, of all pyridine derivatives tested, nicotinamide-N-
oxide, thionicotinamide and nicotinuric acid yielded maximal 
growth stimulation (i.e., 270 to 343 Klett units) in synthetic 
'medium with added thiamine. There was very little growth when 
6-hydroxynicotinic acid or 6-aminonicotinamide was added to a 
thiamine-supplemented synthetic medium. · Higher yield of cells 
obtained upon addition of nicotinamide-N-oxide, thionicotin-
amide or pyridine-3-aldehyde to the growth medium indicates 
that these analogs could be used more effectively than niacin 
in stimulating growth of staphylococci. 
69 
TABLE 7 
Effect of niacin analogs on the growth of s. aureus in a 
compounds tested 
None 
Niacin 
Nicotinarnide-N-
oxide 
Thionicotinarnide 
Nicotinuric acid 
~· } .. cetylpyridine 
Nicotinyldiethyl-
amide 
Pyridine-3-sulfonic 
acid 
6-Hydroxynicotinic 
acid 
6-Arninonicotinarnide 
synthetic medium 
Concn 
µg/ml 
8 
100 
500 
8 
1000 
100 
250. 
500 
100 
Synthetic medium Synthetic medium 
+ thiamine 
Turbiditya in Klett units1 after 
24 hr 48 hr 24 hr 48 hr 
2 6 5 15 
55 54 239 270 
16 28 293 343 
15 28 254 315 
9 28 226 271 
5 11 
13 24 107 150 
' '-~ '• ~ 
·26 40 195 110 
2 6 7 15 
3 3 4 10 
a Turbidity measurements were made at 600 nm. 
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(3) Effect of niacin analogs on growth of different 
~rains of staphylococci and Gram negative bacteria in 
~nthetic medium supplementeq with thiamine. To insure that 
niacin analogs replaced niacin in more than one strain of 
s. aureus additional strains of s. aureus, s. epidermidis and 
a few niacin requiring Gram negative bacteria were tested. 
The results of these growth studies are shown in Table 8. 
The data indicate that 3-acetylpyridine and nicotinyldiethyl-
amide could reproduce the effect of niacin on the growth of 
these organisms. Although the response of the organisms 
varied somewhat, growth stimulation was noted in all the 
(1000 µg/ml) or nicotinyldiethylamide (100 µg/ml) was added 
to a thiamine-supplemented synthetic medium, the growth of 
tested strains of s. aureus and s. epidermidis was stimulated 
(over 150 Klett units), and the cell yields were similar to 
those obtained following the addition of niacin and thiamine 
to the synthetic medium. The data also indicates that 
niacin-requiring S. dysenteriae, P. vulgaris and P. morgani 
successfully used either 3-acetylpyridine or nicotinyl-
diethylamide for growth stimulation. 
(4) Effect of niacin analogs on the glucose 
catabolic pathways of s. aureus. Preliminary experiments 
(Table 1) had shown that addition of niacin and thiamine to 
TABLE 8 
Growth of staphylococci and of Gram negative l:·acteria in a thiamine-supplemented synthetic 
Strain 
medium with niaci:r: or niacin analogs 
Niacin or niacin analogs added to the synthetic medium 
Niacin, 3-Acetylpyridine, 
8 µg/ml 1000 µg/ml 
Nicotinyldiethylamide, 
100 µg/ml 
~~~~~~~~~~~~~~~~~~~~~~~ 
s. aureus 
Towler 
3 
10 
18Z 
Serotype I 
Serotype III 
Serotype IV 
s. epidermidis 
155 
12228 
14990 
Shigella f lexneri 
Proteus morgani 
Proteus vulgaris 
• 
24 hr 
239 
92 
229 
228 
276 
242 
155 
117 
212 
220 
145 
210 
221 
Turbidity in Klett units after 24 and 48 hr 
48 hr 
270 
185 
264 
270 
274 
282 
.264 
228 
212 
215 
137 
200 
195 
24 hr 
134 
171 
184 
166 
189 
192 
215 
llC 
189 
191 
12i. 
20; 
17~·· 
48 hr 
205 
168 
176 
228 
183 
257 
224 
234 
199 
272 
117 
209 
182 
24 hr 
107 
30 
89 
41 
131 
221 
174 
44 
63 
172 
103 
183 
186 
Synthetic medium was devoid of nicotinic acid. 
48 hr 
150 
170 
93 
168 
173 
271 
225 
160 
155 
180 
115 
159 
167 
Turbidity measurements were made at 600 nm; t.he values are the average of two separate 
experiments. 
.··~ 
.t 
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the growth medium had considerable influence on the metabolic 
activities of S. aureus. Therefore, the effect of niacin 
analogs on glucose catabolic pathways of staphylococcal 
cells was investigated. The results of measurements of 
the glycolytic pathways of S. aureus grown in 2% Vitamin-
free Casitone with added niacin analogs and thiamine are 
shown in Table 9. Those compounds which were highly active 
are included in this table. Approximately 18% of the 
glucose was metabolized via the HMP pathway when niacin 
and thiamine were added to the medium. All of the analogs 
listed in Table 9, except 6-hydroxynicotinic·acid and 
6-aminonicotinamide, produced similar increases in the HMP 
pathway utilization and in the TCA cycle activity. For 
instance, when niacin analogs and thiamine were added to 
the growth medium, the amount of glucose catabolized via 
the HMP pathway ranged from 15 to 24~, and the relative 
activity of the TCA cycle was 4.5 to 7.0%, as compared to 
4.5 when niacin and thiamine were added to the growth medium. 
The data also show that the concentrations of the 
• 
analogs required to stimulate the HMP pathway were 100- to 
1000-fold higher thah that of niacin. As shown in Table 9, 
when nicotinamide-N-oxide (100 µg/ml) and 3-acetylpyridine 
(1000 µg/ml) were added to the growth medium, about 15% and 
18.7% of the glucose was oxidized via the HMP pathway, 
r 
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TABLE 9 
Effect of niacin analogs on the glucose catabolic pathways and 
on caenzyme levels of S. aureus 
Addition {µg/ml) to % Glucose Rel. Act. Concn ofa 
Vit.-free Casi tone via HMP of TCA {%) NAD NADP 
None 5.0 0.2 0.3 0.2 
Thiamine { 4) 5.2 1.2 0.4 0.2 
Niacin { 8) 22.0 4.5 4.8 0.6 
Niacin {8) + thiamine (4) 18.0 4.5 3.5 0.4 
nicotinuric acid (8) + 19.9 6.1 2.7 0.4 
thiamine (4) 
Nicotinamide-N-oxide (100) 15.1 7.4· 3.0 0.4 
1..iL_cu11~i..c f' 
' 
\ '"t J 
3-Acetylpyridine (1000) + 
thiamine (4) 18.7 5.2 0.4 0.1 
Nicatinyldiethylamide (100) 
+ thiamine (4) 18.3 5.1 1.0 0.2 
6-Hydroxynicotinic·acid (500) 
+ thiamine (4) 7.8 3.7 0.4 0.3 
3-Pyridylcarbinol (100) 
+ thiamine ( 4) 24.2 4.6 3.2 0.6 
% Glucose catabolized via the EM and the HMP pathway and the 
relative activity of TCA cycle were estimated as described 
previously (see Methods). 
a Nicotinamide coenz0nes values are expressed in µmoles/g 
dry weight. 
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respectively. 
These readings indicate that niacin analogs could 
replace niacin for stimulation of glucose utilization via 
the HMP pathway in s. aureus. The results of these 
. 
experiments also indicate that addition of 6-hydroxynico-
tinic acid to the growth medium did not increase the activity 
of the HMP pathway, although it caused significant changes 
in the TCA cycle activity. Due to these unexpected results 
6-hydroxynicotinic acid was further investigated; the results 
of the experiments are presented in Table 15 of this section. 
Since earlier experiments suggested that some of the 
niacin analogs could completely replace niacin for stimu-
latiori of staphylococcal growth and could also increase 
glucose utilization via the HMP pathway, additional pyridine 
derivatives were investigated. On the basis of the results 
on growth and on the HMP pathway utilization of ~· aureus, 
the niacin analogs have been classified into 4 groups: the 
results are presented in Table 10 with the chemical structure 
of all the compounds shown. 
D. Classification of niacin analogs 
Group I. Analogs stimulating growth and the HMP 
pathway maximally. In this category 25 analogs that 
maximally stimulated HMP pathway utilization and growth in 
2% Vitamin-free Casitone suppliemented with thiamine are 
included. For instance, growth reached a turbidity of 340 
to 360 Klett units while the amount of glucose oxidized 
via the HMP pathway was 15 to 23%. 
Group II. Analogs allowing partial stimulation. 
of growth and of HMP pathway activity. In this category 
the following analogs are included: 3-pyridylacetic acid, 
3-ethylpyridine, 6-chloronicotinamide, dipicolinic acid,. 
picolinic acid, 2-aminonicotinic acid, pyridine-2 and 
-4-aldehyde and 2-chloronicotinic acid. It can be seen 
that most of these analogs were substituted at the 2-, 
4- and 6-positions of the pyridine ring. All of these 
pyridine derivatives partially stimulated growth and HMP 
pathway activity. For example, growth did not exceed a 
turbidity of 160 to 180 Klett units, and the amount of 
glucose utilized via the HMP pathway ranged from 10 to 14% 
in the cells grown in a thiamine supplemented Vitamin-free 
Casitone. Most of the analogs were tested at 3 or 4 
different concentrations. Even when the concentration of 
these analogs was increaed to 5000 µg/ml, there was neither 
increase in the amount of growth nor in the utilization of 
• 
the HMP pathway. 
Group III.· Analogs having no effect on either 
growth or on the HMP pathway. This category included 
4-acetylpyidine, 3-benzoylpyridine, pyridine, pyridoxine, 
2,6-diacetylpyridine, 3,4-diaminopyridine, 2-picoline, 
75 
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4-picoline, 3-hydroxypyridine-N-oxide and other pyridine 
derivatives (Table 10). The analogs were tested using a 
wide range of concentrations and the results showed that 
the addition of these analogs to a thiamine-supplemented 
Vitamin-free Casitone did not increase the growth over the 
control level (70 Klett units). Similarly, increase in 
glucose oxidation via the HMP pathway was not observed. 
For instance, staphylococcal growth reached a turbidity of 
only 60 to 70 Klett units, the same as unsupplemented media, 
and the level of HMP pathway activity remained at 6-8%. 
Group IV. Analogs with complete inhibition 
3-hydroxypicolinic acid, 5-fluoronicotinamide and 
pyrizinamide. The addition of these analogs to the growth 
medium resulted .in complete inhibition of staphylococcal 
growth. 
E. Correlation between growth and the glycolytic 
pathways. 
(1) Influence of niacin and niacin analog 
• 
concentrations on growth and on the glycolytic pathways 
of S. aureus. The results of a number of experiments 
have suggested that growth stimulation and stimulation of 
the HMP pathway activity are independent of each other. 
This was first clearly demonstrated in studies with 
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TABLE 10 
The ability of various pyridine derivatives to replace niacin for 
staphylococcal growth and for .the stimulation of the HMP pathway 
activity and NAD concentration. 
compound 
Group I 
Nicotinic acid 
(niacin) 
Nicotinamide 
. ~ . . - ~' 
\u ... ct(.;..i...L1c:U.ll.J..Uc J 
Nicotinic acid-
N-oxide 
Ethylnicotinate 
Isoniazid 
(isonicotinyl-
hydrazide) 
Isonicotinic acid 
Structure 
COOH 
@g-C2Hs 
Stimulation of 
Growth HMP 
activity 
+ + + + 
+ + + + 
+ + + + 
+ + + + 
+ + + + 
NAD 
con en 
+ + 
+ + 
+ + 
+ + 
+ + 
~·· 
Table 10 (Continued) 
compound Structure 
rsonicotinamide 
Nicotinamide-N-
oxide 
N- i.·ic U1y 111..i.co lir,1a.•· 
mide· 
N-Ethylnicotina-
mide 
Thionicotinamide 
Nicotinuric acid 
(nicotinyl glycine) 
_g_NH2 
0 
@8-1m2 
6H3 
g-NH2 
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Stimulation of 
Growth HMP NAD 
activity concn 
+ + + + + + 
+ + + + + + 
+ + + + T + 
+ + + + + + 
+ + + + + + 
+ + + + 
r 
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Table 10 (Continued) 
Stimulation of 
compound Structure Growth HMP NAD 
activity concn 
Nicotinyldiethyl- @ ,CH2CH3 -C-N,,_ 
aTllide (coramine) CH~CH3+ + + + + + 
Pyridine-3-sulfonic @~-OH 
acid + + + + + + 
"' ~:._vl:;.A.~· .. IJ-,. ~~i;.l~ @ ·"i . . ... y -CH3 
I 
0 
3-Picoline-N-oxide 
@-CH3 
+ + + + + + 
d 
Pyridine-N-oxide + + + + + + 
- 3-Acetylpyridine + + + + + + 
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Table 10 (Continued} 
Stimulation of 
compound Structure Growth HMP NAO 
activity concn 
pyridine-3-aldehyde + + + + + + 
4-Pyridylcarbinol + + + + + + 
3-Pyridylcarbinol rOrCH20H + + + + + + 
~· 
3-Pyridylcarbinol-N- @CH20H 
oxide + + + + + + 
.a, 
0 
@COOH Quinolinic acid + + + + + 
COOH 
• 
5-Chloronicotinic Cl-@-COOH 
acid -0 + + + + - + 
Table 10 (Continued) 
compound 
Group II 
2-Chloronicotinic 
acid 
2-Aminonicotinic 
acid 
3-Pyridylacetic 
acid 
Picolinic acid 
Structure 
~COOH 
~Cl 
@COOH 
NH2 
.......... (S)"Cl12COO'.'. 
@COOH 
Dipicolinic acid HOOC-~COOH 
Pyridine-2-aldehyde @~-H 
Stimulation of 
Growth HMP 
activity 
+ + 
+ + 
+ + 
+ + 
+ + 
+ + 
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NAD 
concn 
ND 
+ 
+ 
-· 
+ 
+ 
Table 10 (Continued) 
compound 
Pyridine-4-aldehyde 
6-Chloronicotina-
mide 
..,, .,.., ' ,_ - - , - . . . ., . 
- ----.,,1.-.a:..1.~---·--
Group III 
3-Benzoylpyridine 
3,4-Diaminopyridine 
3-Hydroxypyridine-N-
oxide 
Structure 
~~-NH2 
Cl-~ 
@_g_@ 
NH2 @-NH2 
@-OH 
I 
0 
Stimulation of 
Growth F~·!P 
activity 
+ 
+ + 
., 
82 
:'.:-IAD 
con en 
ND 
ND 
r 
Table 10 (Continued) 
compound 
2,4-Pyridinedicarbo-
xylic acid 
pyridine 
4-Acetvlpyridine 
Structure 
-COOH 
© 
O=<f-CH3 
fol J ·~ 
CH20H 
Pyridoxine 
HO-©-CH20H 
H3C- _ 
6-Hydroxynicotinic 
acid 
5-Fluoronicotinic 
acid 
HO-
©-COOH 
F-©-COOH 
Stimulation of 
Growth HMP 
activity 
..,., 
83 
NAD 
concn 
ND 
ND 
ND 
r 
Table 1-0(Continued} 
compound 
2-Hydroxynicotinic 
acid 
4-Hydroxynicotinic 
acid 
2-Picoline 
4-Picoline 
Group IV 
6-Aminonicotin-
amide 
3-Hydroxypicolinic 
acid 
Structure 
~lcooH 
~OH 
H2N-
@)8-NH2 
@OH 
COOH 
84 
Stimulation of 
Growth HMP NAD 
activity concn 
. ND 
ND 
i i 
• 
i ND ND 
Table 10 (Continued) 
compound Structure 
5-Fluoronicotina-
mide 
Pyrizinamide 
Symbols: + +, Maximal stimulation 
+, Partial stimulation 
, No stimulation 
i, Inhibition 
ND, Not determined 
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Stimulation of 
Growth HMP NAD 
activity concn 
i ND ND 
i ND ND 
• 
3-pyridylcarbinol (Table 11). There appeared to be two 
distinct effects of 3-pyridylcarbinol (3PC) which are 
concentration-dependent. At a concentration of 2 µg/ml 
growth was stimulated submaximally (147 Klett units) 
while at a concentration of 10 µg/ml of 3PC turbidity 
measurements reached 355 Klett units, indicating that 
maximum growth had been reached. Yet analyses of the 
glucose catabolic pathways by cells grown with different 
levels of 3PC (2 and 10 µg/ml) in the medium showed that 
only 7 to 9% of the glucose was catabolized via the HMP 
pathway with partial stimulation of the TCA cycle activity 
(l.2%). Thus, results trom Table ll indicate that concent-
rations of 10 and 50 µg/ml were sufficient to produce 
maximum growth but not sufficient to stimulate the glycol-
ytic pathways. A concentration of 100 µg/ml or more of 3PC, 
however, was shown to increase both growth and the 
utilization of the HMP pathway maximally in staphylococci. 
It can be seen that along with the maximum growth the 
amount of glucose oxidized via the HMP pathway and the 
relative activity of the TCA cycle were 27.0% and 3.7%, 
repsectively. When a concentration of 5000 µg/ml of 3PC 
was present in the growth medium the amount of growth 
(320 Klett units) and the activity of the HMP pathway 
(22.1%) remained at maximal levels, but a reduction in 
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TABLE 11 
Effect of the addition of different concentrations of 3-pyridyl-
carbinol to a thiamine-supplemented Vitamin-free Casitone 
. 
medium on growth and on glucose catabolism of S. aureus 
Turbidity,b 
% Glucosea 
concen tra ti on TCA cycle catabolized via 
µg/ml Klett units activity (%) EM HMP 
2 147 2.2 92.3 7.7 
10 355 2.2 90.9 9.0 
c;o 1~8 :L 0 9;>, 5 17.5 
100 340 3.7 72.9 27.0 
SQQ 325 4.7 74.9 25.1 
1000 300 3.2 77.2 22.8 
5000 320 1.5 77.8 22.1 
a , Glucose catabolic pathways participation and the TCA cycle 
activity were estimated as described previously (see 
methods). 
b Growth was determined by measuring the turbidity at 600 nm 
after 17 hr. 
The values are the average of two separate experiments. 
-
the TCA cycle activity from 4.7% to 1.5% was noted. 
Since such separate effects on growth and on the HMP 
pathway were observed depending on the concentration of 
the analog used in the growth medium, studies were 
conducted with various concentrations of niacin and the 
results are shown in Table 12. The results indicated 
that 0.05 µg/ml of niacin in thiamine-supplemented 
Vitamin-free Casitone produced almost maximal growth 
(300 Klett units) without stimulating the utilization of 
the HMP pathway for glucose oxidation. Only 9-10% of the 
glucose was oxidized via the HMP pathway. As the concentr-
ation ot niacin wa~ increased from n.o5 to 0.25 µg/ml, 
a gradual increase in the activity of the HMP pathway 
was noted. For example, maximum utilization of glucose 
via the HMP pathway (21.6%) occurred at a concentration 
of 0.25 µg/ml of niacin. When the niacin concentration 
,in the medium was increased to 1000 µg/ml, there was a 
reduction in the growth rate as well as in the operation 
of the HMP pathway. For instance, decline in the turbidity 
readings of 162 Klett units was observed, while the 
relative activities of HMP and the TCA cycles were 13.4% 
and 3.3%, respectively. With the addition of 2000 µg/ml 
there was complete inhibition of staphylococcal growth. 
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TABLE 12 
Effect of the addition of different concentrations of niacin to 
a thiamine-supplemented Vitamin-free Casitone on growth and on 
glucose catabolism of s. aureus. 
-
% Glucosea 
Nia=in added Turbidity,b TCA cycle catabolized via 
µg/ml Klett units activity (%) EM HMP 
o.oo 42 0.7 90.0 9.1 
0.05 300 2.0 89.2 10.8 
0.10 326 3.6 84.5 13.5 
0.25 335 5.6 78.4 21.6 
o. c;o ~ J C\ ., c; 7q 4. ::>O .. 5 
2.00 345 4.5 82.0 18.0 
5.00 341 2.9 82.5 17.5 
50.00 335 4.3 80.3 19.6 
500.00 330 3.9 75.6 24.4 
1000.00 162 3.3 86.6 13.4 
. 
2000.00 11 
a Glucose catabolic pathway participation and TCA cycle activity 
were estimated as described previously .(see Methods). 
b Growth was determined by measuring the turbidity at 600 nm 
after 17 hr. 
L 
The values are the average of two separate experiments. 
The niacin content of 2% Vitamin-free Casitone is 
0. 0013 µg/ml. 
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TABLE 13 
Effect of the addition of different concentrations of pyridine-
3-sulfonic acid to a thiamine-supplemented Vitamin-free Casitone 
medium on growth and on glucose catabplism of s. aureus 
% Gfucosea 
concentration Turbidity,b TCA cycle catabolized via 
µg/ml Klett units activity (%) EM HMP 
250 201 1.7 89.3 10.7 
500 272 1.2 92.0 8.0 
1,000 380 1.4 92.7 7.3 
2,000 405 3.0 85.8 14.2 
5,000 345 3.5 80.6 19.4 
10,000 430 3.5 68.4 31.6 
20,000 425 3.2 70.0 30.0 
a Glucose catabolic pathway participation and TCA cycle 
activity were estimated as described previously (see Methods). 
b Growth was determined by measuring the turbidity at 600 nm 
after 17 hr. 
The values are the average of two separate experiments. 
l 
These results with niacin substantiated the present 
study's previous observation in the case of 3PC where 
low concentration of the vitamin was required for maximum 
stimulation of growth and higher concentration was needed 
for maximum operation of the glycolytic pathways. 
Table 13 showed similar results; different concentr-
ations of pyridine-3-sulfonic acid in Vitamin-free 
Casitone were used with added thiamine. Essentially 
similar results were obtained as those reported with 
niacin and 3-pyridylcarbinol (Tables 11 and 12), except 
that there was a wider margin between the concentrations 
---:i.--- _.:: for m;,.i.:,d:r;.:.i.l gro•.r1th and for .Lna~d1:1al II.HP ~timul:i.tion. 
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F. Effect of niacin analogs on the glycolytic pathways. 
(1) Effect of 6-aminonicotinamide on the HMP 
pathway of S. aureus. The results with the 6-substituted 
analog of niacin, 6-aminonicotinamide (6-AN), on the 
growth and on the activity of the HMP pathway are shown 
in Table 14. When 100 µg/ml of this analog of niacin 
was added to Vitamin-free Casitone, it completely inhibited 
growth of s. aureus. The turbidity of <~5 Klett units 
obtained after incubation for 24 to 48 hr was probably 
due to traces of vitamins present in the growth medium. 
There was no further increase in the growth when the 
incubation was continued for as long as 72 hr ( results 
TABI,E 14 < 
~ 
Effect of 6-aminonicotinamide (6-AN) on th~ gl~cose catabolic pathways of S. aureus 
Addition to 
the 2% Vitamin-
free Casitone 
growth medium 
None 
None 
Niacin (2 µg/ml) + 
thiamine (2 µg/ml) 
Niacin (2 µg/ml) + 
thiamine (2 µg/ml) 
Niacin (0.05 µg/ml) 
+ thiamine (2 µg/ml) 
Niacin (0.05 µg/ml) 
+ thiamine (2 vg/ml) 
+ 6-AN (100 µg/ml) 
Additions to 
the resting cells 
grown in column 
1 medium 
None 
6-AN (100 µg/ml) + 
thiamine (2 µg/ml) 
6-AN (100 µg/ml) + 
thiamine (2 µg/ml) 
6-AN (100 µg/ml) + 
thiamine (2 µg/ml) 
None 
None 
Incubation 
time 
hr 
3 
3 
6 
2 
2 
.. 
TCA cycle 
activity (%) 
0.4 
0.2 
4.5 
2.3 
2.4 
2.0 
% Glucose 
catabolized via 
HMP EM 
8.3 91. 7 
2.4 97.6 
20.3 79.7 
8.9 91. 9 
9.0 91.0 
0.3 99.7 
The cells were grown for 17 hr under various conditions as indicated in the 1st column. 
After growth they were washed with and suspended in 0.05 M phosphate buffer with added 
niacin, thiamine or 6-AN as shown in the 2nd =olumn. The flasks were placed on a rotary 
shaker for the indicated time. These cells were then harvested and used in the usual 
manner as described previously (see Methods). ,: t 
not shown in Table 14). Due to the lack of growth in medium 
with added 6-AN, analyses of the glucose catabolic pathways 
were not performed. 
It was possible to study the effect of 6-AN on the 
glycolytic pathways under resting cell conditions. When 
staphylococci that had previously grown in unsupplemented 
Vitamin-free Casitone were washed and incubated in phosphate 
buffer (0.05 M, pH 7.0)-glucose (0.9%) ·medium containing 
6-AN(lOO µg/ml} and thiamine (2 µg/ml} for 2-3 hr, there 
was a reduc:;tion in ,the utilization of the HMP pathtTq.Y., . 
from 8.3% to 2.4% (Table 14). Decrease in the activity 
nf rhE'! HMP parhway re~uJting from thP. addition ot 6-aminu-
nicotinamide was also observed in niacin grown cells which 
utilized HMP pathway maximally. For instance, when 
staphylococcal cells were first grown in supplemented 
Vitamin-free Casitone and then incubated in buffered 
-glucose with 6-AN and thiamine, the activity of the HMP 
pathway was unaffected for the first 3 hr. As the 
incubation continued for 6 hr, a marked decrease in the 
utilization of the HMP pathway (from 20.3% to 8.9%) was 
noted. This strongly indicates that 6-AN in some manner 
inhibits the activity of the HMP pathway in s. aureus. 
The results of the experiments (Table 14) also 
indicated that when the staphylococcal cells were grown in 
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Vitamin-free Casitone with added thiamine (2 µg/ml), niacin 
{0.05 µg/ml) and 6-aminonicotinamide (100 µg/ml), there 
was no inhibition of growth .. Turbidity of 300 Klett units 
was reached within 17 hr of incubation {results not shown 
in the table). Analyses of the glucose catabolic pathways 
of cells grown under these conditions demonstrated that the 
oxidation of glucose via the HMP pathway was reduced to 
0.3%, the lowest value ever recorded in the present study. 
Such inhibition in the HMP pathway activity by 6-AN has 
been previously shown in animal cells (22,40,41) .• 
~ $2) Effect of 6-hydroxynicotinic acid on the 
·.1.CA \,.;.:ych .. acL.i.v.i.t.y or s. au.reus. lmalysis of ··~ ... .:..~;....::. ~ • .:.::c.:.~~ 
analogs {Table 9) has indicated that some of the niacin 
analogs at high concentrations can completely replace 
niacin for stimulation of both growth and HMP pathway 
activity. None of the compounds affected the TCA cycle 
activity unless thiamine was present in the growth medium. 
The results of glucose catabolic pathways with the addition 
of 6-hydroxynicotinic acid {6HN) to the medium are shown 
in Table 15. The findings demonstrated that this 6-hydro-
xylated derivative of niacin, when added alone to the 
growth medium, did not stimulate staphylococcal growth. 
Similarly, the activities of the glycolytic pathways 
94 
were not increased. For instance, the growth within 17 hr 
reached a turbidity of 75 Klett units (not shown in Table 
15) and the amount of glucose catabolized via the HMP 
pathway and the TCA cycle activity were 10.7% and 1.5%, 
respectively. When the staphylococcal cells were grown 
in Vitamin-free Casitone with added 6-hydroxynicoti!l_ic 
acid and thiamine, utilization of the HMP pathway remained 
less than 10% while the relative activity of the TCA cycle 
was increased by 3-fold (from 1.5 to 4.2%). It should 
be mentioned here that 6-HN or thiamine when added singly 
had no stimulatory effect on the TCA cycle; nor did the 
aadition of b-HN·and niaci..n·together to the growth medium 
increase the TCA cycle activity (Table 15). 
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Observation of staphylococcal cells previously 
cultivated in 2% Vitamin-free Casitone containing 1000 µg/ml 
of 6-HN (Table 15) and then incubated with niacin under 
resting conditions showed stimulation of both HMP pathway 
and TCA cycle activities. Under these conditions the 
amount of glucose oxidized via the HMP pathway was 20.5% 
and the relative activity of the TCA cycle was approximately 
5.8%. As shown previously (Table 1) that addition of 
niacin alone did not stimulate the TCA cycle activity, 
but increases only in the HMP pathway were noted. This 
r 
TABLE 15 
Alteration of the TCA cycle activity of s. aureus by 6-hydroxynicotinic acid (6-HN) 
Addition to the Addition to the 
2% Vitamin-free resting cells % Glucose 
Casi tone growth grown in column TCA cycle catabolized via 
medium 1 medium .'lCtivity ( % ) EM HMP (%) 
6-HN (1000 µg/ml) None 1. 5 89.3 10.7 
6-HN (1000 µg/ml)-
niacin (2 µg/ml) None 0.9 76.4 23.6 
6-HN (1000 µg/ml) Niacin (2 µg/ml) 5.8 79.5 20.5 
6-HN (1000 µg/ml)-
thiamine (2 µg/ml) None 4.2 91. 7 8.3 
Niacin (2 µg/ml) 6-HN (1000 µg/ml) 0.7 78.5 21.5 
Niacin (2 µg/ml)-
thiamine (2 µg/ml) None 4.5 81. 6 18.4 
Staphylococcal cells were grown for 17 hr in :he medium shown in the ·1st column, 
washed with and suspended in O. 05 M phosphat ·~ buffer. In some cases 6-HN or niaci·n 
were added, as indicated in the 2nd column, :•.) the resting cells. The flasks were 
incubated for 2 hr and the estimation of glu ::•Jse catabolic pathways was performed as "° 
described previously (see Methods). m 
.t 
r 
L 
.. 
indicated that 6-HN was acting like thiamine in stimulating 
the TCA cycle. The data from Table 15 also showed no 
increase in the TCA cycle if the cells were grown previously 
in Vitamin-free Casitone with added niacin and then incub-
ated with 6-hydroxynicotinic acid. 
(3) Effect of N-oxides of pyridine derivatives 
on growth and on glucose catabolism. Table 16 presents 
the results of the studies of various pyridine derivatives 
and their N-oxides on growth, HMP and on the TCA cycle 
activities of s. aureus. in general it was observed 
that all N-oxides tested were better growth stimulators 
than the corresponding parent compound. 3-Hydroxypyridine-
N-oxide was an exception. For instance, addition of 
pyridine or 2-picoline did not stimulate either the growth 
or the metabolic activities of staphylococci. However, 
upon the addition of the corresponding N-oxides, pyridine-
N-oxide and 2-picoline-N-oxide, growth was stimulated as 
was glucose utilization through the HMP pathway. The 
concentration of N-oxides required to yield maximal cell 
growth was generally lower than the concentration of the 
parent compounds or of other pyridine derivatives. 
G. Uptake of 14c-niacin and niacin analogs. 
(1) Uptake of niacin-14c by niacin-deficient 
S. aureus. Incubation of staphylococcal cells previously 
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TABLE 16 
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Effect of the addition of pyridine compounds and their N-oxides 
to a thiamine-supplemented Vitamin-free Casitone on staphylo-
' !; r coccal growth and glucose catabolism 
compound 
tested 
(concn µg/ml) 
Nicotinic acid 
(2 µg) 
Nicotinic acid-
N-oxide (100) 
Nicotinamide (2) 
Nicotinamide-N-
oxide (100) 
3-Pyridylcarbinol 
(100) 
3-Pyridylcarbinol-
N· .. oxidc (:; 0 C) 
Pyridine (1000) 
Pyridine-N-oxide 
(500) 
2-Picoline (1000) 
2-Picoline-N-
oxide (1000) 
3-Picoline-N-
, oxide ( 5 0 0 ) 
3-Hydroxypyridine 
(1000) 
3-Hydroxypyridine 
-N-oxide (1000) 
Turbidity 
(17 hr) 
Klett units 
340 
315 
342 
360 
335 
J15 
61 
330 
65 
340 
360 
55 
96 
TCA cycle 
activity (%) 
4.5 
4.3 
4.2 
7.4 
3.3 
3 .. 2 
0.8 
2.2 
0.6 
3.0 
4.4 
1.1 
1.5 
% Glucose 
catabolized via 
EM HMP 
81.5 
75.1 
80.9 
84.9 
77.2 
82.1 
93.0 
84.3 
94.6 
80.2 
81.5 
93.7 
89.5 
18.5 
24.9 
19.9 
15.l 
22.8 
7.0 
17.7 
5.4 
19.8 
18.5 
6.3 
10.5 
% Glucose catabolized via the EM and the HMP pathways and the 
relative activity of the TCA cycle were estimated as described 
previously (see Methods). 
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Figure 6. Uptake of 14c-niacin by nonproliferating niacin-
deficient s. aureus. Washed niacin-deficien~ 
cells equivalent to 3 mg (dry weight)/nl ~ere 
incubated in buffered olucose containina 
14c-niacin, 5 µg/ml (ll4508 C?m/ml of niacin). 
The 14c content of the cells was determined at 
the indicated time. 
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grown in unsupplemented Vitamin-free Casitone medium in 
t . . t 37 c t . . 14 . . d . reac ion mix ure at con aining C-niacin resulte in 
an accumulation of the radioactive vitamin within the cells 
(Fig. 6). Niacin uptake was found to be linear with time for 
about 30 to 40 min , reaching a maximum at 60 min. Further 
incubation, for periods up to 120 min , did not result in 
an additional uptake of the vitamin. 
(2) pH Dependence of niacin transport. The 
results of studies on the uptake of niacin at different pH 
values are presented in Fig. 7. The vitamin uptake was 
strongly influenced by the pH of the medium, the optimum pH 
from S.S to 8.0, there was a reduction in the uptake of the 
n 
vitamin. On the basis of these results it is concluded that 
niacin enters the staphylococcal cells by a pH sensitive 
mechanism, the optimum hydrogen concentration for niacin 
,uptake being approximately S.S. 
(3) Temperature dependence of niacin transport. 
The results of studies on niacin uptake by staphylococci at 
different temperatures are shown in Fig. 8. The niacin uptake 
by resting cells of S. aureus was influenced by the tempera-
ture of reaction mixture. The maximum uptake was shown to 
occur at 50 c. Cellular adsorption of niacin was found to 
contribute little to the amount of niacin uptake, since brief 
l 
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pH 
Figure 7. Effect of pH on 14c-niacin transoort in 
s. aureus. Conditions for the experiment 
were same as described in Fig.6 except that 
0.2 MK phosphate buffer was used in the pH 
range from 5.5 to 8.0. The samples were 
removed at the end of 60 min for the 
estimation of radioactivity in the cells. 
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Figure 8. Effect of temperature on 14c-niacin transport 
in s. aureus. The conditions for the experiment 
were same as described in Fig.6. The staphyloc-
occal cells were incubated for 60 min at 
indicated temperature, and the radioactivity 
in the cells was determined as described 
previously (see Methods). 
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exposure of cells to niacin at 0-4C resulted in insignificant 
niacin uptake. Since energy generation within the cells is 
very low at this temperature, this also suggests that niacin 
uptake is energy dependent. 
(4) Energy requirement. Many microbial transport 
systems are dependent upon, or are stimulated by, the presence 
of an energy source (43). In the experiments reported here, 
the addition of glucose to the medium slightly stimulated the 
uptake of niacin in vitamin-deficient staphylococcal cells 
(Fig. 9). Also, the addition of glucose to the incubation 
significantly stimulated niacin uptake in the staphylococcal 
(results are not included in the Fig. 9). The mechanism 
of stimulation of niacin uptake under this condition in the 
present study is not well understood. 
(5) Effect of niacin concentrations. The results 
'Of experiments on the effect of niacin concentration on the 
transport system in staphylococci are presented in Fig. 10. 
The rate of niacin uptake increased with increasing niacin 
concentrations in the medium and tended to become saturated 
at lo-7 M. 
(6) Inhibition of niacin uptake by niacin analogs. 
A measure of the specificity of the niacin transport system 
was obtained by investigating the effect of several 
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Figure 9. Effect of glucose on 14c-niacin transoort in 
S. aureus. Washed niacin-deficient cells 
equivalent to 3 mg (dry weight)/ml were 
incubated in K phosphate buffer (pH 7.0) 
containing 14c-niacin, 5 µg/ml (114508 cpm/ml) 
and/or 1% glucose. Radioactivity in the cells 
was determined at various intervals as 
described previously (see Methods). 
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Figure 10. Effect of niacin concentration on the uotake 
of niacin by niacin-deficient S. aureus. 
Experimental conditions were as described in 
Fig. 6. Radioactivity in the cells was 
determined after 60 min of incubation. 
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structurally related compounds on 14c-niacin uptake (Table 
17). The presence of excess unlabeled niacin or of the 
pyridine analogs containing a substituant in the 3 position, 
3-pyridylcarbinol, quinolinic acid, 3-hydroxypyridine, 4-
chloronicotinic acid and 2-, 4-, and.5-hydroxynicotinic acid, 
inhibited the accumulation of radioactive niacin. However, 
pyridine-N-oxide and isoniazid, neither of which are sub-
stituted at the 3-position of the pyridine ring, did not 
inhibit the uptake process. Thus, the results indicated that 
niacin uptake by s. aureus is mediated by a transport system 
having structural specificity for niacin and closely related 
CUltllJOUlld::>. 
(7) Exchange between intracellular niacin and 
extracellular niacin and its analogs. Many compounds which 
are accumulated by cells can be eluted from the intracellular 
pool by exchange with extracellular compounds of the same or 
similar structure (15). This has been cited as evidence for 
the existence of transport carrier systems in the cell mem-
brane. In the present experiments (Table 18) the exchange 
between intracellular niacin and the extracellular niacin or 
niacin analogs did not occur. However, it should be pointed 
out that after niacin entered the cells, it was quickly con-
verted to nicotinamide coenzymes NAD(P) and its inter-
mediates and thus did not remain in a free state (46, 33). 
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TABLE 17 
Inhibition of 14c-niacin transport by niacin 
analogs 
% Inhibition 
Radioactivity in 14c-niacin 
Unlabeled addition cell counts/min uptake 
None 12,850 o.o 
Niacin 15 100.0 
3-Pyridylcarbinol 110 99.1 
Quinolinic acid 135 98.9 
Pyridine-N-oxide 11,325 o.o 
Isoniazid 11,765 8.5 
3-Hydroxypyridine 55 99.6 
2-Hydroxyniacin 75 100.0 
4-Hydroxyniacin 74 100.0 
5-Hydroxyniacin 60 99.5 
4-Chloronicotinic acid 905 91.0 
Staphylococcal suspensions containing 3 mg (dry weight) of cells 
in 0.05 MK phosphate buffer, pH 7.0 and l' glucose were exposed 
simultaneously to 2 µg/ml of l~c-niacin (114508 cpm) and 2 mg of 
unlabeled analog. After 30 min, the cell suspensions were 
filtered, washed and then counted, as described previously (see 
Methods). 
L 
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TABLE 18 
exchange between intracellular 14c of cells preloaded with 14c-
n_iacin and with unlabeled extracellular niacin or niacin analogs 
Radioactivity (cpm/ml, cells) after addition of unlabeled 
Time Quinolinic 3-Pyridyl-
min Buffer Niacin acid carbinol Isoniazid 
0 12,110 12,545 11,500 10,907 12,041 
30 12,049 11,961 11,509 11,595 11,157 
60 1.1,570 11,106 11,916 10,751 10,569 
120 11,618 10,671 10,253 10,807 11,326 
eel.ls preloaded with 14c-niacin as described previously (see 
Methods}, were added at a concentration of 3 mg/ml (dry weight) 
.,to flasks containing 0.05 M,potassium phosphate buffer pH 7.0, 
1% glucose and either unlabeled niacin or niacin analogs at a 
· final. concentration of 2 mg/ml. Cells were incubated at 37 C, 
samples removed at intervals and the' cellular radioactivity was 
r determined. 
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(8) Uutake of labeled quinolinic acid and isoniazid 
by niacin-deficient S. aureus. Staphylococcal cells took up 
comparatively little isoniazid or quinolinic acid. Fig. 11 
and 12 show the uptake of two different concentrations of 
isoniazid and quinolinic acid by staphylococcal cells under 
resting cell conditions. As the external concentration of 
radioactive quinolinic acid was raised to 500 µg/ml, the rate 
of uptake was found to be slightly increased during the 2 hr 
incubation period. The uptake, although low (l.0%), was 
found to be maximal at a concentration of 500 µg/ml (Fig. 12). 
Similarly, small differences were observed in the uptake of 
from 10 to 500 µg/ml in the medium (Fig. 11). The uptake of 
isoniazid was also time-dependent, as more 14c-isoniazid 
entered the cells at the .end of a 6 hr compared to a 2 hr 
period. Analyses of the glucose catabolic pathways under 
·identical conditions showed that there was an increase in the 
utilization of the HMP pathway from 6.2 to 20.4% when the 
concentration of isoniazid was increased from 10 to 500 µg/ml. 
Similar results were obtained with quinolinic acid (results 
not shown in Fig. 11 and 12). Therefore, these results 
indicated that although the uptake of the niacin analogs 
isoniazid and quinolinic acid was low (2%), it was sufficient 
to bring about the metabolic changes similar to those caused 
by niacin. 
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Figure 11. Uotake of isoniazid-14c by nonproliferating 
niacin-deficient S. aureus. Cells equivalent 
to 3 mg (dry weight)/ml were incubated at 
indicated time, in reaction mixture 
containing either 10 or 500 µg/rnl of 
isoniazid-14c (222635 cprn/ml, final concentr-
ation). The uptake of the analog by the cells 
was determined as described previously. 
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Figure 12. Uotake of quinolinic acia-14c by nonpro-
liferating niacin-deficient s. aureus. 
Experimental conditions were as described 
in Fig.11 except isoniazid was replaced 
with quinolinic acia-14c. 
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IV. DISCUSSION 
In. the present study an attempt has been made to investi-
~ gate some of the £actors that might control the degree to 
~ t which the glucose catabolic pathways of staphylococci are 
F' 
t 
~ 
' r 
modified, as a result of the addition of either niacin and /or 
thiamine to the growth medium. 
The importance of an adequate supply of niacin and thiamine 
in glycolysis (i.e., the conversion of glucose to pyruvate or 
lactate without regard to metabolic pathways) has been studied 
in staphylococci by Kligler et al. (61). According to these 
investigators 2.5 times more glucose was used when both vitamins 
were present in the growth medium than was used when niacin 
. dlone we:u:; µresent. Results from the prPSPnt- studv n;:n1p ~1 qo 
indicated that there was an increase in the rate of glycolysis 
when these vitamins were added to certain vitamin-deficient 
growth media (Fig. 2), although addition of thiamine alone to 
the medium did not result in stimulation of glucose utilization. 
Thus, in the present study there were no differences in glucose 
utilization by staphylococci grown in a medium containing 
either niacin or niacin and thiamine. The difference between 
• these results and those of Kligler et al (61) perhaps stems 
from the use of resting cells in the present studies, previously 
grown in the presence of vitamins, whereas Kligler et al. (61) 
analyzed glucose utilization from the medium by actively growing 
cells. 
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In the present study it was found that, following the 
I. 
t addition of niacin or niacin and thiamine to Vitamin-free ~· 
I 
casitone, 18 to 22% of the glucose was oxidized via the HMP 
pathway by the cells. Surprisingly, the addition of thiamine 
alone to the growth medium did not result in a stimulation of 
the glucose oxidation through the HMP pathway (Table 1). This 
was an important finding since thiamine, in the form of 
diphosphothiamine (DPT), is required as a coenzyme in this 
pathway. If the DPT coenzyme is missing or is present in 
amounts that limit the expression of the full activity of the 
enzyme, the effect would be the same as the absence of the 
:-::1Z~'TI~, id.th <J. rcsul tant block in tl:c a.:-thrit;." c·f .the HMr 
pathway. It has been shown that the addition of thiamine to 
thiamine-deficient red blood cells stimulated transketolase 
activity and HMP pathway, indicating that transketolase was 
the rate-limiting step in the HMP pathway of red blood cells 
(102). A similar limiting role for transketolase in both yeast 
and rat liver has also been demonstrated (6, 87), and the 
addition of thiamine has induced transketolase in yeast (124). 
Data from this dissertation have shown that when thiamine 
was added to the medium, there was no stimulation of glucose 
oxidation through the HMP pathway in staphylococci. The lack of 
the HMP stimulation by added thiamine may perhaps reflect that 
there was already present an excess of the vitamin for trans-
ketolase activity. On the basis of these findings alone, it is 
l 
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not possible to exclude the rate-limiting or regulatory role of 
DPT-linked transketolase in the HMP pathway of s. aureus. How-
ever, glucose oxidation via the HMP pathway increased markedly 
following addition of niacin, without any thiamine and under the 
conditions that precluded enzyme formation (Table 5). It may be 
concluded that the activity of DPT-linked transketolase is not 
limiting the activity of the HMP pathway under these c·onditions. 
All living cells contain thiamine, if it is not supplied 
exogenously then the cell must synthesize it. Although, thiamine 
was originally considered to be a vitamin required for the growth 
of staphylococci (62), Idriss and Blumenthal (48) obtained 
mooerar:e qrowth of' staphylococci. in n n, aC"!:l n-suppJ emented $yn-
thetic medium~ free of thiamine ... The low rate of .. growth .and 
increased HMP activity were consistent even after repeated 
transfer of the cells in the absence of thiamine. Based on these 
findings, they concluded that there must be a limited endogenous 
synthesis of thiamine in the cells. Since the results of 
radiorespirometric studies with the cells grown in niacin 
supplemented growth medium lacking thiamine have shown that the 
stimulation of the HMP cycle can occur in the absence of added 
thiamine, then it is clear that the staphylococci can synthesize 
enough thiamine to allow the HMP pathway to act at a maximal 
rate. Thus, thiamine is not limiting the activity of the HMP 
pathway in staphylococci as it does in the red blood cells of 
animals. 
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When staphylococci were grown in a vitamin-deficient medium 
(2% Vitamin-free Casitone), with either added niacin or thiamine 
alone, there was no stimulation of the TCA cycle activity. In-
creased TCA cycle activity (10-fold) was only detected when both 
niacin and thiamine were added to the growth medium. The 
mechanism of this stimulation, only after the addition of both 
niacin and thiamine, is not presently understood, although the 
coenzymes forms of both vitamins are required for the activity 
of a number of enzymes in the TCA cycle. 
Relatively large variations in the degree of utilization of 
the glycolytic pathways of staphylococci were observed when the 
cell8 were g1.own i11 different grow'Lh media. ~'or example, \Yhen 
staphylococci were grown in Vitamin-free Casitone-containing 
both vitamins, the amount of glucose catabolized via the HMP 
pathway was 18% as compared to a value of 35% when the cells were 
grown in synthetic medium supplemented with niacin and thiamine 
(Table 1). Similarly, it had been shown that the addition of 
niacin and thiamine to Trypticase growth medium (which contains 
glucose} yielded cells that oxidized 46% of the glucose via the 
HMP pathway (81}. Thus, these results demonstrate that the 
relative degree of utilization of the HMP pathway in S. aureus 
is significantly affected by the nature of the growth medium. At 
present, the reasons for the absolute differences in the degree 
of utilization of the glycolytic pathways of staphylococci grown 
in different growth media are not fully understood. However, it 
r • 116 
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iS clear in all instances studied that the addition of niacin or 
niacin and thiamine to the growth medium (Vitamin-free Casitone, 
synthetic medium or Trypticase broth) results in the growth of 
cells which have the property of oxidizing increased percentages 
of glucose via the HMP pathway. To minimize complications· 
resulting from the use of complex media, Vitamin-free Casitone 
medium was used for most of the experimental work. 
Until now we have considered the percentage of glucose 
molecules metabolized by the EM and by the HMP pathways. It is 
possible that one may receive a distorted view if the actual 
amounts of glucose traversing these pathways are not considered • 
l''('lT Pxamp.l e, in mutant~ of ~monella 'FYPh!,!11U£!·E.12 and, ot 
Escherichia coli, deficient in phosphoglucose isomerase, the EM 
pathway was found not to operate efficiently because of this 
enzyme deficiency and the rate of both growth and glucose 
utilization was only about 20% of that noted in the parent 
strain. Although, the mutants used less total glucose, the rate 
of utilization of glucose via the HMP pathway (3 µmoles/mg/hr) 
was approximately the same as that observed in the parent strains 
(29, 30). Consequently, the percentage of glucose oxidized by 
the HMP pathway increased, but only because the amount going 
through the EM pathway decreased. An analysis of the results 
with staphylococci indicated that an analogous situation occurred 
When the percentage of glucose being oxidized via the HMP pathway 
L 
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increased after the addition of niacin. The difference was that 
the amount of glucose being oxidized via the EM pathway remained 
relatively constant (or increased slightly) while the amount 
oxidized via the HMP pathway increased significantly. 
The usual percentage of glucose catabolized via the HMP 
pathway in niacin-deficient cells is 6%, and since there are 
only 2 pathways, by difference, the amount catabolized via the 
EM pathway is 94%. About 33% more glucose was used by niacin-
rich cells than was used by cells grown in the absence of the 
added vitamins, and one might ordinarily expect this extra 
glucose to be catabolized by the two glycolytic pathways in the 
experiments (Table 1) indicated that in niacin-rich staphylococci, 
the amount of glucose oxidized via the HMP pathway increased to 
about 20% while, by difference, the amount oxidized via the EM 
was reduced to 80%. 
In niacin-rich cells the actual amounts of glucose traversing 
the EM pathway each hour was 9.6 µmoles/hr (12 µmoles glucose/hr 
x 80% glucose oxidized via EM= 9.6) and by difference, since a 
total of 12 µmoles/hr were used, the amount of glucose oxidized 
'via the HMP must be 2.4 µmoles/hr. In a similar manner, vitamin-
deficient cells used 8.5 µmoles/hr via the EM pathway (9 µmoles/ 
hr~ 94% glucose oxidized via EM= 8.5) and by difference, since 
a total of 9 µmoles of glucose/hr were used, the amount of glucose 
l 
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ox~<?:1- Zt'.1i ·1ia the HMP pathway was 0. 5 µmole/hr. Thus the 
~nclusi.•11 1 of niacin in the growth medium resulted in a 
relativ.:J-; slight increase in the amount of glucose utilized 
v~a the r:.i1 pathway (from 8. 5 to 9. 6 µmoles/hr), while there was 
a 5-folii .i.ncrease (from O. 5 to 2. 4 µmoles/hr) in the glucose 
oxidati•111 through the HMP pathway. Although the addition of 
?iacin ILsulted in a decreased percentage of glucose being 
metabol i l<:d via the EM pathway (from 94% to 80%), the actual 
a.m~unt 11r glucose used via this pathway increased slightly. 
!h~ !n~f~9sed rate of glycolysis in niacin-rich cells was 
P!"!!Il?!"il/ due to the additional passage of about 2 µmoles of 
~!~~()~o ~!f~ilized via the EM pathway remained essentially the 
same in ~bth niacin-rich and niacin-deficient staphylococcal 
c::ells. '1'1-zis _is the reverse of the findings by Fraenkel (29) 
in ent2 1 I~ bacteria where the bacterial mutants, with deficien-
~~es or "Hl EM enzyme, had significantly reduced amounts of 
glucos~ ' · ·a· d · h h b 1 · 1 '·"'tng oxi ize via t e EM pat way ut re ative y 
~<::m~t9n t 'lmounts via the HMP pathway. 
• 
Wlku one disintegrates staphylococci and assays the levels 
of the i 11•lividual glycolytic enzymes in vitro under conditions 
that art: • •Ptimal for substrate and coenzyme concentrations, such 
assays •1" not necessarily yield information about the activity 
of thes,, 0 nzymes within the cells. These analyses, however, 
reveal t J,c. potentialities (i.e., the maximum activity of that 
l 
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enzyme under optimal conditions) of the individual enzymes. 
Enzymes which play a requlatory role in determining the pro-
portion of glucose that is metabolized via one of the two 
pathways will also suffer the same limitations during in vitro 
assays. Consequently, an attempt was made throughout the 
present study to use both in vivo and in vitro techniques to 
estimate the activity of a metabolic pathway. 
The pattern of 14co2 production from 14c-labelled glucose 
by staphylococci which had been grown in media supplemented with 
both vitamins, strongly indicated the stimulation of both the 
HMP pathway and the TCA cycle. Measurements of the enzyme 
glycolytic pathways were due to the synthesis of _increased 
amounts of enzymes. Thus, there were striking and consistent 
increases in the activity of G6PD and 6PGD when the HMP pathway 
operated maximally and similar increases in ICD were noted when· 
the TCA cycle activity was stimulated (Table 1 and 2). Under 
various growth conditions, the activities of the two HMP enzym'?" 
(G6PD and 6PGD) were shown to be closely related to the level o= 
staphylococcal glucose catabolism via the HMP pathway, as indi-
cated by the ability to convert C1 of glucose to co2 • A similc::_-
relationship was found between ICD levels and the TCA cycle 
activity, as indicated by the release of C02 from C6 of glucose. 
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Th~ markedly increased levels of G6PO (ca. from 45 to 160 
units} that were found in staphylococci following the additon 
of the vitamins to the growth medium were accompanied by a 
tripling in the percentage of glucose oxidized via the HMP 
pathway in S. aureus (Table 2 and 3). Such increased utili-
zation of the HMP pathway and accompanying increased content of 
HMP enzymes have also been observed in yeast and mammalian . 
systems (80, 87, 109). 
Experiments with cell-free extracts, in which the indivi-
dual enzyme may be added to those already present in the extract, 
have also yielded some useful information about the role of 
For example, the addition of phosphohexose isomerase and glucose-
6-phosphate dehydrogenase (G6PO) to a hemolysate·of normal red 
blood cells resulted in an increase in the amounts of glucose 
metabolized via both the EM and the HMP pathways. When hemo-
lysates were prepared from G6PD deficient blood cells, added 
phosphohexose isomerase was without any apparent effect, in-
dicating that the enzyme was already present in excess, whereas 
• the addition of G6PD caused a 4-fold increase (from 13.1 to 
45.8%} in the amount of glucose oxidized by the HMP pathway, 
thus confirming its rate-limiting role. It should be noted that 
these experiments with cell-free extracts were carried out on the 
Presence of optimal concentrations of NADP required for the HMP 
l 
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pathway stimulation. Since the present studies with staphy-
1ococci resulted in the conclusion that the enzymes were not 
~ 1imiting the rate of glucose oxidation via the HMP pathway, 
t 
[-' 
r 
~ 
f· 
similar experiments were not performed. 
The results of the present experiments indicated that when 
staphylococci were grown in supplemented Vitamin-free Casitone, 
increased G6PD activity was always paralleled by increased IL.'1P 
pathway activity (Table 2 and 3). From this observation it 
appeared that the level of G6PD in some manner limited the 
activity of the HMP pathway in staphylococci. 
The first indication that the enzyme levels were probably 
I 
of the gluc~se was metabolized via the HMP pathway when s. 
aureus was grown in synthetic medium containing excess amounts 
of niacin and thiamine, compared to only 18% when these vita-
mins were added to Vitamin-free Casitone (Table 1). In spite of 
the increased level of activity of the HMP pathway in the intact 
cells, the activities of G6PD and 6PGD, two of the key enzymes 
in the HMP pathway, from extracts derived from the synthetic 
medium, were only 2/3 as much as those derived from cells grown 
in Vitamin-free Casitone with added niacin and thiamine (Table 2). l Therefore , it appeared that increased amounts of the glycolytic 
r 
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enzymes were not necessary for more active operation of the HMP 
pathway in staphylococci. A similar situation existed for the 
TCA cycle. 
In order to get more direct information on the role of 
enzymes in the regulation of the H.MP pathway, we undertook ex-
periments with resting cells. Under resting cell co~ditions 
protein synthesis in the cells is minimized due to the absence 
of a nitrogen source in the incubation medium. Although some 
turnover of protein is expected in the cells, there can be no 
net increase in protein synthesis. Thus under resting cell 
conditions the effect of vitamins on metabolic pathways can be 
examined with minimal changes in enzyme levels. 
Radiorespirometric studies showed that the incubation of 
vitamin-deficient staphylococci, possessing a relatively low 
percentage of glucose oxidation via the HMP pathway, with the 
vitamins in the buffered-glucose medium converted them to 
staphylococci with glycolytic characteristics similar to those 
of cells that had been grown in the presence of the vitamins 
(Table 4). The amount of glucose catabolized via the HMP 
pathway was approximately 19%, whether the vitamin supplementa-
tion had been made under growing or resting cell conditions. 
The stimulatory effects of the vitamins on the activity of the 
TCA cycle were similarly observed. Enzyme analyses indicated 
that the levels of the two key HMP enzymes were only 30% of 
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those observed under growing conditionsr even in spite of a 
greater utilization of glucose via the HMP pathway (Table 3 
and 5). This clearly indicated that the HMP enzymes G6PD and 
6PGD were not limiting the activity of the HMP pathway in vivo. 
To further ensure that protein synthesis was not proceeding 
in the resting cells as a result of the utilization of amino 
acids from either an endogenous amino acid pool, and/or from a 
low level of protein turnover, one of the following three 
antibiotics, inhibitors of protein synthesis, chloramphenicol, 
actinomycin D or puromycin, were added along with the vitamins 
at concentrations ranging from 6 to 100 µg/ml.. Growth of the 
chloramphenicol and actinomycin D at concentrations of 6 and 
0.6 µg/ml, respectively (120). The findings of the experiments 
were essentia~ly the same as those wi.th the resting cells 
suspensions, namely, that none of the antibiotics were able to 
prevent the stimulation of the HMP pathway or the rise in the 
levels of NAD and NADP, following the addition of niacin to the 
vitamin-deficient staphylococci. Furthermore, the enzyme levels 
• 
in the HMP pathway did not increase in the cells with the in-
creased HMP activity .(Table 6). Surprisingly, it was found that 
actinomycin D actually stimulated utilization of the HMP pathway 
and also increased NAD level. The mechanism of this stimulation 
by actinomycin D is not presently understood and was not 
investigated further. 
r 
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Based on the results just discussed it was concluded that 
the stimulation of the HMP pathway caused by the addition of 
niacin was not related in any way with the synthesis of enzymes. 
Since the levels of the glycolytic enzymes within the 
cells are not the rate-limiting factors in staphylococcal 
carbohydrate metabolism and do not play a regulatory role in 
the HMP pathway of s. aureus, any changes in enzyme levels 
within cells resulting from the addition of the vitamins to 
the growth medium are probably secondary to the changes in 
nicotinamide coenzyme levels. This will be discussed further 
in this section • 
.Ln contra.st to tne present resuJ.ts with staphylococci, the 
levels of enzymes have been claimed to play a significant role 
in determining the degree to which the EM and HMP glycolytic 
pathways are utilized.in yeast (87). The findings with the 
yeast were based on the fiact that when yeast were grown with 
nitrate as the nitrogen source, instead of with amino acids as 
the nitrogen source, there was an increase in the levels of the 
enzymes, G6PD and transketolase, along with increased 14co2 
production from glucose-1-14c, indicating more active operation 
of the HMP pathway. It was also noted that the addition of the 
antibiotic, cycloheximide, to the growth medium prevented both 
new enzyme synthesis and increased activity of the HMP pathway. 
From these findings, it was concluded that new enzyme synthesis 
125 
was necessary for increased operation of the HMP pathway and 
that there was a strong correlation between the level of G6PD 
and the degree of operation Qf the HMP pathway in yeast. 
In the present study, it was also found that the levels 
of G6PD and 6PGD paralleled the degree of utilization of the 
HMP pathway in staphylococci under growing conditions (Table 3). 
However, in the present study suitable experimental conditions 
were found which demonstrated that the increased utilization of 
the glucose through the HMP pathway, as a result of the addition 
of vitamins, occurred without the synthesis of these enzymes 
(Table 3). On the basis of these findings, it is concluded that 
the HMP pathway in staphylococci. This may just represent 
examples of different controlling factors in different microbes. 
The measurement of enzyme. level~. in the cells that had been 
incubated with chloromphenicol eliminated the possibility of any 
enzyme formation in the present study through activation or 
assembly of polypeptide precursors, such as is thought to occur 
in the formation of enterotoxin B by S. aureus, even in the 
presence of chloramphenicol (74). 
Induction of G6PD synthesis by coenzymes, vitamins and 
metabolites has been observed in animal and microbial cells (3, 
10~, 123, 124). For instance, thiamine in the form of 
diphosphothiamine induced the synthesis of pyruvate decarboxylase 
r 
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in yeast, with resultant increase in glycolysis (123). This 
finding was based on the observation that pyruvate decarboxylase 
activity increased by 50% during the incubation of yeast cells 
with glucose and thiamine and by 300% when the cells were in-
cubated with glucose, thiamine and a nitrogen source. Simi-
larly, an increase in the pyruvate decarboxylase activity was 
prevented by the inclusion of proflavine, p-fluorophenylalanine 
or 5-fluorouracil in the incubation medium. These results 
indicated that the higher activity of pyruvate decarboxylase 
after incubation with thiamine was due to the stimulation of 
de ~ synthesis of the enzyme and not an activation of pre-
, .. •:,- ·: ~ ... I "~ ' ·~ '* ", .... ' .~.\: ~ ':~' ¥" .. ~ ...., ]'. 
thiamine also induced transketolase (124). There ·are al.so other 
examples which support the finding_that cofactors of an enzyme, 
in addition to re~ulating-the activity of the existing enzyme, 
may influence the amount of the protein moiety of the same 
enzyme that is found in vivo (37). However, ins. aureus, 
there was no increase in the levels of the glycolytic enzymes, 
when the vitamins were added under resting cell conditions, 
although the glycolytic pathways were maximally stimulated 
(Table 4). The additional use of antibiotics in the experiments 
(Table 6) eliminated any possibility of new protein synthesis 
occurring in the cells. Based on these results it can be con-
eluded that there was no induction of glycolytic enzymes in 
~ ~· aureus by the added vitamins. 
L 
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Since the enzyme levels were not responsible for regula-
ting the relative amounts of glucose being metabolized by the 
EM and the HMP pathways in st.aphylococci, we next considered 
the possible regulatory role of NAD and NADP levels. NADP 
has been shown to be an important regulator of the HMP cycle 
in various microbial and mammalian systems (24). In numerous 
in vitro experiments it has been shown that the addition of 
either electron acceptors which would reoxidize NADPH to NADP 
or of enzyme systems capable of converting NADPH to NADP, 
resulted in increased glucose oxidation via the HMP pathway 
(121). Thus the NADP concentration and/or the rate of NADPH 
glucose degradation via the HMP pathway. 
In cooperative studies with R. Hoo (46) in this laboratory, 
it was observed that the levels of nicotinamide coenzymes in 
staphylococci always increased in parallel ·with increased 
levels of glucose oxidation via the HMP pathway following the 
addition of niacin either under growing or resting cell condi-
tions (Table 6). For instance, it was demonstrated in staphylo-
coccal cells that when niacin was added to the growth medium, 
there was a 15-fold increase in NAD and a 2-fold increase in 
NADP levels at the same time there was a 3- to 4-fold increase 
in ·glucose oxidation via the HMP pathway. This suggested that 
either the levels of NAD and/or NADP played a regulatory role 
for the amount of glucose oxidation via the HHP pathway. 
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The regulatory role of NADP in the activity of the HMP 
pathway in various microorganisms has been well established (14). 
However, NAD has not been previously proposed to be involved in 
controlling the overall activity of the HMP pathway. It is 
difficult to imagine how NAD would control some of the enzymatic 
reactions of the HMP pathway since NAD does not serve as a 
coenzyme in this pathway, with the exception of few microbes 
(13, 125). In staphylococci, the enzymes G6PD, 6PGD and ICD 
all had a specific coenzyme requirement for NADP in the three 
assay systems. It should be noted that only crude cell-free 
extracts served as enzyme sources in the present studies. The 
-
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of NADP (0.1 mM) did not influence the rate of enzymatic 
reactions. These results suggested that the NAD levels did not 
stimulate the activity of HMP enzymes in vitro, and therefore, 
it appears that the role of NAD in regulating the HMP pathway in 
staphylococci, is probably due to some mechanism other than the 
direct stimulation of G6PD and 6PGD activities. 
Nozawa and Mizuno (86) observed a reduction in the intra-
• 
cellular NAD level in niacin-requiring E. coli during the course 
of "starvation''. The NAD content decreased to one tenth of 
normal level after two hr of incubation of washed cells in 
buffered glucose. Therefore, similar experiments were designed 
to determine whether such a variation in NAD could be observed 
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in staphylococci during starvation and, if so, to correlate the 
NAD and NADP levels with the degree of utilization of the two 
glycolytic pathways. 
Incubation of washed resting staphylococcal cell sus-
pensions that had previously been cultivated in Vitamin-free 
Casitone containing niacin (0.5 µg/ml), resulted in a reduction 
in the HMP pathway from 18% to 10%, while the intracellular NAD 
level decreased from 2.2 to 1.5 µmoles/g (Fig. 3). During this 
incubation for 6 hr in the vitamin-free buffered glucose 
solution, while the NAD level decreased, the NADP level remained 
constant or increased very slightly. However, the addition of 
niacin {~UU µg/m~J to the incubation medium at the end ot the b 
hr period led to a simultaneous increase in the HMP pathway 
utilization (to 19%) and the NAD content (to 4 µmoles/g) without 
a corresponding increase in the NADP level (Fig. 3). Replacing 
niacin with pyocyanin (an electron acceptor) in the incubation 
medium also resulted in an increase in the utilization of the 
HMP pathway (from 10 to 22%) without increasing the coenzyme 
levels. These results suggested that NAD and pyocyanin probably 
acted in the same manner while stimulating the activity of the 
HMP pathway, by reoxidizing NADPH to NADP. In the case of 
pyocyanin, the action was directly on the NADPH, while the NAD 
probably acted via the transhydrogenase system with NAD being 
reduced to NADH during the concomitant oxidation of NADPH to 
NADP. 
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On the basis of these results it appeared that a certain 
intracellular NAD level was necessary, in addition to the level 
of NADP, in order to allow this expanded operation of the HMP 
pathway in S. aureus. Under the conditions studied here, with 
a relatively constant NADP level of about 0.4 µmoles/g, as the 
NAD concentration was reduced to a value below 2.2 µmoles/g, 
the HMP pathway ceased to operate maximally. The importance of 
the NAD level in allowing the augmentation of glucose oxidation 
via the HMP pathway was further substantiated by the finding 
that when the NAD level was restored to 2 µmoles/g following 
the addition of niacin at the end of the 6 hr incubation period 
level. These results suggested that the NAD leve-1 in some 
manner played a regulatory role in the degree of operation of 
the HMP pathway in staphylococci. 
In highly oxidative organisms such as Pseudomanas saccha-
rophila and Pseudomonas fluorescens, which predominantly 
utilize the HMP and/or ED pathways, with little or no EM path-
way, intracellular levels of NADP are relatively low. For 
example, the level of NADP in these two organisms 0.8 µmoles/g 
and 0.04 µmoles/g, respectively (71). In such organims the 
potential rate-limiting effect of NADP on the activity of the 
HMP and ED pathways has been overcome by the presence of active 
NADPH oxidase and of transhydrogenase (24) resulting in a very 
rapid reoxidation of NADPH to NADP. 
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In S. aureus the level of NADP was found to be in the 
range of 0.6 µmoles/g when the HMP pathway was being utilized 
maximally (45). This level of NADP was similar to those found 
in other facultatively aerobic and anaerobic microbes, such as 
E. coli, B. subtilis and P. saccharophila (71). In the present 
study with S. aureus no definite correlation was found between 
the transhydrogenase and NADPH oxidase activities and the degree 
of utilization of the HMP pathway. The low activities of these 
enzymes (Table 5) in s. aureus could be explained on the basis 
that the EM pathway still served as a major glucose catabolic 
route (78%), even when the HMP pathway operated maximally (22%). 
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oxidase, found in S. aureus, were probably sufficient to gene-
rate NADP for the H.MP pathway activity. Such is the case in 
B. subtilis and also in E. coli, which do not use the HMP path-
way as the major route for glucose catabolism and which also 
contain relatively low amounts of NADPH oxidase and transhydro-
genase (24). Furthermore the finding that the expanded acti-
vity of the HWF pathway in S.aureus required a NAD level of 
greater than ca. 2 µmoles/g can best be interpreted to mean 
that the transhydrogenase system is involved in NADP regenera-
tion even in the facultative anaerobes such as S. aureus. To 
our-knowledge this is the first instance that the exoerimental 
evidence supports this concept in any microbe other than the 
strict aerobes such as pseudomonas. 
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One of the major conclusions drawn from the experiments 
just discussed was that the addition of niacin to the growth 
medium stimulated the glucose utilization via the HMP pathway 
by increasing the cellular levels of both the glycolytic enzymes 
and the nicotinamide coenzymes, NAD(P). However, through the 
use of resting cell conditions~ it was demonstrated that the 
increased levels of enzymes were secondary effects and that 
certain intracellular NAD and/or NADP levels were required for 
the regulation of the HMP pathway in ~- aureus. 
The results of the present experiments have indicated thus 
far that either the level of NAD and/or NADP may be involved in 
. . . 
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oxidized via the HMP pathway in staphylococci. In order to 
obtain staphylococcal cells in which there were further varia-
tions in the coenzyme levels, some niacin analogs were employed 
in the present studies. The niacin analogs isoniazid and 6-
aminonicotinamide have been known to reduce the intracellular 
levels of nicotinamide coenzymes in both microbial and 
mammalian systems (40, 41, 122). Surprisingly, it was found 
• 
in the present studies that many of the niacin analogs were able 
to completely replace the niacin requirement for staphylococcal 
growth. Therefore, further studies with the analogs were 
pursued. 
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Previous investigations with niacin analogs had indicated 
that quinolinic acid, picolinic acid, isonicotinic acid, 
nicotinyldiethylamide, and ce~tain other pyridine derivatives, 
when added to the growth medium at concentrations of l0- 4M 
(ca. 0.15 µg/ml), could not replace niacin as a growth factor for 
staphylococci (62, 68, 69). These failures to replace niacin and 
to permit growth were not due to the toxicity of the compounds 
since staphylococcal growth resumed following the addition of 
nicotinamide to media containing the various compounds. The 
results of the present studies, which are summarized in Table 10, 
confirmed these findings when the analogs were used at concen-
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the analogs in the growth medium (containing thiamine) was 
increased from a level of 10 to a level of 100 or 1000 µg/ml 
all of the analogs in Group I (Table 10) stimulated staphylo-
coccal growth to approximately the same degr~e as niacin. For 
example, 3-AP or PSA added to a thiamine-supplemented 2% Vitamin-
free Casitone growth medium at a concentration of 10 µg/ml 
produced a turbidity of 70 Klett units, approximately the same 
as that of the control. However, when the concentration of the 
analogs was increased to 1000 µg/ml in the medium, the turbidity 
increased to 343 Klett units. This compares to a value of 340 
Klett units when niacin was used at a concentration of 2 µg/ml. 
Similar results were obtained with most of the other analogs from 
r 
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Group I (Table 10). In the absence of added thia~ine, however, 
the growth stimulation was either absent or minimal (Fig. 4 and 
Table 7), even when high conqentrations of niacin analogs were 
used. 
When analogs from Group II (Table 10) were added to a 
thiamine supplemented Vitamin-free Casitone medium even at con-
centrations of 1000 µg/ml, they were unable to stimulate growth 
maximally. For example, when either 6-chloronicotin~uide or 
picolinic acid was added to the growth medium at a concen-
tration of 1000 µg/ml turbidity readings of only.170-180 Klett 
units were obtained. This amount of growth was only approxi-
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addition of any compound from Group I. It is conceivable that 
maximum growth (ca. 340 Klett units) might occur with Grou-::> II 
analogs if even still higher concentratio~ of analogs were em-
ployed. This suggestion is based on the results of ex~eri~e~ts 
with various concentrations of Group I analogs on the grohth of 
staphylococci. For instance, data from Table 13 in~icats~ t~at 
at a concentration of PSA of 250 µg/ml only half maximu.~ grohth 
occurred (201 Klett units) compared to the maximtL~ growth of 
400 Klett units that resulted following the addition of 2COO 
µg/ml or more of PSA. 
Analogs from Group III failed to support staphylococcal 
growth in 2i ther Vi ta"1in-free Casi tone or in synthetic r::ec.2. ;.;..-:-.. 
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while the analogs in Group IV were inhibitory to even the low 
levels of growth able to occur in the basal media. Concen-
trations of Group III analogs_ as high as 1000 to 5000 µg/ml 
were unable to stimulate the growth above the control level. 
The complete inhibition of staphylococcal growth by the Group 
IV analogs, 6-AN, 5-FlN, pyrizinamide and 3-hydroxypicolinic 
acid, is in agreement with the findings of other workers (47, 
104, 114). 
The use of completely synthetic media for the growth 
studies showed that many niacin analogs were successfully 
utilized and converted into nicotinamide coenzymes by staphylo-
P~- ~--~---- -~~~~~--
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of any of the 25 Group I analogs to a thiamine supplemented 
synthetic medium completely replaced the niacin requirement for 
staphylococcal growth (Table 7). With the addition of 3-AP or 
NNO to synthetic media with added thiamine, turbidity readings 
of 205 and 343 Klett units, respectively, were obtained. These 
values are comparable to that obtained with added niacin (270 
Klett units). Analogs from Group III and IV also failed to 
stimulate staphylococcal growth in the synthetic medium, con-
firming the results in the Vitamin-free Casitone medium. 
To insure that the niacin analogs were effective in more 
than the Towler strain of s. aureus, 10 additional strains of 
S. aureus, 3 strains of S. eoidermidis and 3 niacin-requiring 
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Gram ~egative bacteria were tested for their ability to utilize 
niacin analogs in place of niacin. Our results (Table 8) showed 
that 3-AP (1000 µg/ml) or NDA (100 µg/ml) when added to thiamine 
supplemented Vitamin-free Casitone, stimulated the growth of all 
strains of S. aureus and S. eoidermidis. Although the growth 
response varied somewhat from strain to strain, the growth stim-
ulation by 3-AP and NDA was generally similar to that of niacin. 
Similarly, Proteus vulgaris, Proteus morgani and Shigella 
flexneri also utilized 3-AP and NDA as a growth factor in place 
of niacin. When Shigella flexneri was grown in Vitamin-free 
Casitone containing added 3-AP and thiamine, _turbidity measure-
units obtained from the addition of niacin and thiamine. 
Successful utilization of 3-AP, PSA and NNO as a growth factor 
by dysentry bacilli and by other Gram negative bacteria has 
been previously observed (82, 92). Thus the results of these 
studies strongly indicate that the utilization of niacin analogs 
is a general feature among the niacin requiring microbes. 
The discrepancies between the negative results of previous 
• investigators (25, 63, 68, 69) and the results of the present 
studies are probably due to the concentrations of analogs and 
the type of growth media employed in their studies. Previous 
workers had failed to observe any stimulatory effect on the 
growth of S. aur9us due to the fact that very low concentrations 
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(10-5 to 10-4M) of analogs had ;pen used in their studies. 
These concentrations were simil0r to the concentration of niacin 
usually required for staphylocos~al growth. The results re-
ported in this dissertation (FiJ. 4 and 5) indicated that the 
concentrations of the analogs rc:: 0 iuired were at least 100- to 
1000-fold higher than the 0.1 ~J/ml of niacin necessary to 
support the maximal growth of s. dureus. As will be discussed 
later, the need for such high c0ncentrations is probably due to 
the lack of an active transport :;ystem for the analogs in 
staphylococci. 
The data from the present study (Fig. 4 and 5) indicated 
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were tolerated by staphylococci ·.·: i. thout any adverse effects on 
th~i~ ability to grow, eventually a concentration was reached 
which caused growth inhibition. :or example, addition of 
niacin, at concentration rangins ~=om 0.1 to 500 µg/ml stimu-
lated maximal staphylococcal gro~~~ and at least 0.25 µg/ml 
was needed for maximal stimula ti,':: of the HMP pathway. However, 
at a concentration of 1000 µg/ml ~22re was a 50% reduction in 
growth, while glucose oxidation :>.:-ough the HMP pathway de-
creased from 21.6% to 13.4% (Tabl~ 12). When niacin was added 
to the medium at a concentration ~= 2000 µg/ml, there was complete 
inhibition of staphylococcal gro~~~- The inhibitory effect of 
large concentration of niacin or ~:3 analogs was probably due to 
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the nutritional imbalance in the medium and is in agreement with 
the findings of other workers that concentration of niacin above 
1 mg/ml inhibited growth of niacin-requiring bacteria (65). 
Fig. 5 shows that there was no lag in the growth of 
staphylococci in the presence of the niacin analogs. This in-
dicated that the stimulatory effects of niacin analogs on 
staphylococcal growth were not due to the selection of mutants 
capable of using the analogs. If such a selection of mutants 
were involved, then one would have expected to find either 
longer or shorter lag periods during growth on various occasions. 
Such growth variations in present study were not observed. 
while investigating the effect of pyrithiamine, a thiamine 
analog, on ~- aureus, had shown that the ability to use pyri-
thiamine involved the selection of mutants. Furthermore, these 
mutants possessed properties indicating that major biochemical 
changes were present in the mutant cells. Present data has 
conclusively demonstrated that the addition of either niacin 
or niacin analogs produced similar biochemical changes in the 
staphylococcal cells, even under non-growing conditions (Table 
9 and 10). Consequently, the involvement of mutants can be 
eliminated from consideration. 
- Studies with specifically-labelled 14c-glucose have demon-
strated that the niacin analogs successfully replaced niacin in 
r 
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stimulating the utilization of the HMP pathway in staphylococci 
(Table 9). The results indicated that when niacin or its 
analogs (Group I) were added to the growth medium, the increased 
amount of glucose utilized via the HMP pathway (18-24%) and the 
increased relative activity of the TCA cycle (4-5%), were 
similar in both cases. The mechanism of glucose oxidation via 
the HMP pathway is discussed later in this section. 
The interesting finding that lower concentrations of niacin 
or niacin analogs were required for maximal growth than the con-
centrations of these substances that were required for maximal 
stimulation of glucose oxidation by the HMP pathway, was first 
'l'h11c::_ rni:> rinn1r1nn 
of 10 µg/ml of 3-pyridylcarbinol to the growth medium produced 
maximal growth stimulation (355 Klett units) although the cells 
obtained from this medium only oxidized about 10% of added 
glucose via the ID1P pathway. A concentration of 100 µg/ml of 
this analog was required for both maximal growth and maximal 
glucose oxidation through the HMP pathway (27%). Following this 
discovery, the effect of lower concentrations of niacin were 
examined for their effects on both growth and the HMP pathway 
participation. It was found that addition of 0.05 µg/ml of 
niacin to the medium resulted in maximal growth stimulation 
while maximal stimulation of glucose utilization via the HMP 
pathway required a concentration of at leasE 0.25 µg/ml (Table 
12). The absolute difference between the concentrations of 
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niacin allowing maximal growth stimulation and maximal stimu-
lation of the HMP pathway was only o.2 µg/ml and had not been 
observed prior to the studies with the analogs. With the 
analogs such as PSA or 3-pyridylcarbinol this difference was 
much more readily apparent. For example, with 3-pyridyl-
carbinol the difference was 90 µg/ml and for PSA it was 1750 
µg/ml. These findings clearly proved that the maximal opera-
tion of the HMP pathway was not a necessary requirement for 
the maximal growth of staphylococci. 
The minimal contribution of glucose oxidation through the 
HMP pathway under conditions that will still allow staphylococci 
. . 
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though the usual percentage of glucose oxidized by staphylococci 
via the HMP pathway is 7 to 8% in Vitamin-free Casitone growth 
medium not supplemented with niacin, this value was reduced to 
0.3% when 6-A.t."'\J was included along with niacin in the growth 
medium (Table 14). Streightoff (114) had previously shown 
that the growth inhibitory effect of 6-AN was nullified by the 
inclusion of niacin in the growth medium. However, he had 
not studied any biochemical properties of these cells. In the 
present study when 100 µg/ml of 6-AN was added to a medium con-
taining 0.05 µg/ml of niacin, the staphylococci were able to 
grow at their normal rate. However, when these cells were used 
to estimate the glucose catabolic pathways, only 0.3% of the 
r 
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gluco~e was found to be oxidized via the HMP pathway, the lowest 
value ever observed with staphylococci. Apparently this small 
fraction is able to supply the pentoses and NADPH necessary for 
growth. With the use of isotopic studies, it has been shown 
that in E. coli, about 1% of glucose carbon passing through the 
oxidative part of the HMP pathway is converted into phosphori-
bosyl pyrophosphate, an intermediate for nucleotide synthesis 
(11, 55). On the basis of these findings it appears that one of 
the primary functions of HMP pathway is to generate NADPH for 
reductive biosynthesis. 
From these data several conclusions can be drawn: 
growth and for stimulation of glucose utilization 
via the HMP pathway. 
2 • . _High levels of operation of the HMP pathway 
(i.e., 20-30%) are not required for maximal 
growth rate. When as little as 1% of the 
glucose is being catabolized via the HMP 
pathway, that rate is sufficient to allow 
• 
staphylococci to grow at their maximal rate. 
under the conditions studied. 
3. The addition of niacin or its analogs can 
stimulate the utilization of the HMP pathway 
and the TCA cycle activity (when thiamine is 
present) in the complete absence of growth. 
r 
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Impaired function of the HMP pathway in §_. aureus due to 
the addition of 6-AN under growing and resting cell conditions, 
was observed in our study (Table 14). Such an inhibition of 
the HMP pathway has already been demonstrated following 6-AN 
administration in mammalian system (22,40,41,64). The toxic 
effects in animals, resulting from the administration of 6-AN 
have been shown due to the formation of NAD(P) analogs in vivo, 
which are inhibitory to a number of NADP-dependent dehydro-
genases (17,41,64). Herken (41) observed that there was a 
considerable accumulation of 6-phosphogluconate compared to 
glucose-6-phosphate, in the brains of 6-AN treated animals 
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indicating a significant reduction in 6PGD activity. Accu-
mulation of these substrates was not observed in the control 
animals which did not receive 6-AN. 
In parallel studies in this laboratory, it was shown that 
the addition of 6-AN to the growth media resulted in a similar 
accumulation of glucose-6-phosphate and 6-phosphogluconate (1.3 
and 7.3 µmoles of G6P and 6PG/g, respectively) in staphylococci 
(46). This 5-fold increase of 6PG over G6P strongly suggested 
that the site of action of 6-AN in s. aureus was also at the 
6PGD level. In the present study the activities of G6PD and 
6PGD from 6-AN grown cells were not tested. However, the resu-
ts of the isotope experiments with intact cells demonstrated 
r 
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that l~co2 evolution from glucose-1-14c was substantially 
reduced, indicating that the two initial enzymes (G6PD and 
6PGD) of the HMP pathway were inhibited. On the basis of these 
findings, it is not possible to conclude that reduction in the 
HMP pathway utilization, accompanied by a 10-fold increase in 
the substrates in S. aureus, was due to the formation of 
coenzyrne analog of NAD(P). However, it is clear from the 
present study that in S. aureus the site of action of 6-AN 
is also at 6PGD level, as observed in marrunalian system (41). 
The results of the analog study indicated that none of the 
hydroxylated pyridine derivatives replaced niacin, either for 
;:>--·!lo-·· _._ __ ._ 
from Table 15 suggested that 6-hydroxynicotinic acid (6-HN) 
stimulated the TCA cycle activity under certain conditions and 
this thiamine-like effect was observed only in the cells that 
had been previously grown in the presence of 6-HN and subseque-
ntly incubated in a medium containing added niacin. The mecha-
nism for this stimulation of the TCA cycle activity by 6-HN 
is not presently understood. One possibility is that the analog 
• 
may cause derepression of thiamine biosynthesis in staphylococci 
so that the cells may have enough of this vitamin for the 
active operation of the TCA cycle. Derepression of thiamine 
synthesis in ~· coli and Enterobacter species by compounds 
such as adenine and phenylalanine, has been demonstrated (58,83). 
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Ellinger et al. (25) suggested that the growth promoting 
activity of some pyridine derivatives for various niacin 
requiring bacteria was due to slight contamination with niacin 
or niacinamide of the pyridine derivatives. The compounds 
which stimulated growth fully, were also considered to be 
heavily contaminated. These suggestions were not based on any 
direct experimental evidence. However, since 3-acetylpyridine 
(3-AP) and other analogs were required in such large amounts 
(1000 µg/ml) for staphylococcal growth stimulation, the possi-
bility was considered that this growth stimulation might 
actually be due to contamination of the 3-AP by niacin or 
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niacinamide are not volatile, large quantities of this compound 
were spotted on paper chromatograms. Using different solvent 
systems, UV spectra and chemical reactions, no contamination of 
. . . . . 
3-AP by niacin or niacinamide was detected. With this technique 
it would be possible to detect as little as 0.05 µg of niacin in 
the 1000 µg of 3-AP. Thus, when 5000 µg of 3-AP containing 0.05 
µg of niacin was spotted on paper, this low amount of niacin was 
detected in the mixture. On the basis of these findings and the 
limitation of the technique, any contaminating amount of niacin 
must be present in a concentration less than 0.05 µg in 1000 µg 
of 3-AP. Such a low level of niacin, even if it was present, 
could not account for the results reported in the present study 
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with the analogs. Using similar techniques it was also observed 
that the growth stimulatory effects of NDA and quinolinic acid 
were not due to their contamination with niacin and/or niacina-
mide. 
The possibility was considered that the stimulatory effect 
of the analogs on growth, glycolysis and on nicotinamide 
coenzymes was due to the induction or derepression of niacin 
biosynthesis. In Saccharomyces cerevisiae the addition of the 
thiamine analog oxythiamine (15 µg/ml) to the growth medium 
stimulated the biosynthesis of thiamine (107, 108). In the 
present studies, with the use of 14c-quinolinic acid and 
. ~ .. 
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analogs was directly incorporated into the nicotin-amide coenzymes 
(46) • If the induction of niacin synthesis in the staphylococcal 
cells was due to the addition of niacin analogs, then the in-
corporation of radioactivity from the analogs into NAD(P) would 
not have occurred. On the basis of these results it was con-
eluded that the stimulation of NAD(P) synthesis as a result of 
the addition of niacin analogs was not due to the induction or 
the derepression of niacin biosynthesis in staphylococci. The 
precise mechanism of this formation of nicotinamide coenzymes 
from the analogs is not presently understood. From the isotopic 
data, and from various other types of evidence, it was concluded 
that the stimulation of growth, of glycolysis and of NAD and 
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NADP synthesis in staphylococci were all due to the increased 
biosynthesis of unaltered nicotinamide coenzymes from the 
analogs after the analogs had been modified biochemically 
within the cells (46). 
The need for high concentration of analogs to bring about 
changes in the growth and in biochemical characteristics was 
thought to be due to the reduced permeability for these 
compounds. 
Considerable evidence was obtained that the uptake of 
14c-niacin by staphylococci proceeded by a physiological 
mechanism involving active transport (Fig. 6 to 10). The re-
I - 1,- - __ _ --
~!:" __ .... _ 
- -- - --- -i::-
and retained against a concentration difference and that the 
transport appeared to be temperature-dependent (Fig. 8) and pH 
sensitive (Fig. 7). It should be noted that the niacin is 
rapidly converted to NAD and NADP within the cells (33, 46). 
Data presented in Fig. 10 showed that the rate of niacin up-
take was increased when there were higher niacin concentrations 
in the medium and that this process was saturated at a concen-
tration of lo-7M (Fig. 10). Similarly, the maximal rate of 
niacin uptake was found to occur at pH 5.5 and at 50 C. There 
was relatively no uptake either at 4 C or at pH 4.0 and 8.0 
(Fig. 7 and 8), indicating the transport system was both pH 
and temoerature dependent. 
r 
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The uptake of 14c-quinolinic acid and 14c-isoniazid by 
niacin-deficient staphylococcal cells was negligible when the 
suspensions were incubated with 1, 2, 10 or 50 µg/ml of the 
analogs, for 2 hr at 37 C, in the presence of 1% glucose. Only 
a 2% increase in the uptake was observed when the concentrations 
of either isoniazid or quinolinic acid were increased to 500 
µg/ml. Although the 14 c of the carbonyl-labeled does not end up 
in NAD and NADP, the quinolinic acid-6-14 c does (46). Although 
this uptake was low when compared to that of niacin, it was 
sufficient to induce the biochemical changes in the staphylo-
coccal cells reported earlier (Table 18). Similarly, the uptake 
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changes in pH or in temperatures. On the basis of these results, 
it appeared that the niacin analogs entered the staphylococci by 
simple passive diffusion •. An analogous situation was noted by 
Kawasaki et al. (57), who found that the uptake of thiamine in 
E. coli occurred by an active transport process. Upon isolation 
of a mutant of E. coli that was defective in thiamine uptake, 
they were able to demonstrate that the thiamine concentration 
required for the half maximal growth for this mutant strain was 
approximately 0.037 µg/ml, which was a concentration about 150-
fold higher than that required for the parent strain. Results 
with staphylococci in the present study also indicated that 
100- to 1000-fold higher concentrations of niacin analogs than 
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niacin were required for maximal growth, due to the lack of an 
active transport for the analogs~ 
E. coli, S. aureus and ~-· megateri um (resistant to 
isoniazid) have been shown to utilize extremely small amounts of 
isoniazid compared to sensitive strains of .Mycobacteriurn 
tuberculosis (128). In the present study it was also found that 
staphylococci took up extremely small amounts of isoniazid, even 
after exposure of cells for 6 hr (Fig. 11). On the basis of the 
uptake studies with the analogs (Fig. 11 and 12), it is strongly 
suggested that the need for high concentration for growth 
stimulation and for the biochemical changes, is due to the 
_.....,. _____ -.C -- --L.!.--.-. 
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aureus. The analogs probably enter the cells by simple passive 
diffusion after which they are able to cause changes similar to 
those caused by niacin. 
r 
V. SUMMARY 
S. aureus catabolized glucose by both the Embden-Meyerhof 
(EM) and the hexosemonophosphate {HMP) pathways, as determined 
with 14c-1abeled glucose. The relative activities of these 
pathways, and of the TCA cycle, were influenced by the in-
clusion of niacin and/or thiamine in the growth medium. When 
> 0.25 µg/ml of niacin was added to 2% Vitamin-free Casitone, 
the proportion of glucose metabolized via the HMP pathway by 
S. aurues was stimulated 3-fold. When 0.1 µg/ml of niacin 
was added, the growth was maximally stimulated but increased 
NAD(P) synthesis or HMP pathway activity was not observed. 
Under growing conditions, increased glucose oxidation via the 
HMP pathway and TCA cycle activity were correlated with the 
increased synthesis of NADP-specif ic glucose-6-P dehydrogenase 
·and isocitrate dehydrogenase, respectively. When the vitamin 
supplementation was made to resting niacin-deficient cells, 
metabolic changes similar to those in growing cells occurred, 
even in the presence of protein inhibitors such as chlor-
amphenicol, puromycin or actinomycin D. .Since the specific 
activities of the enzymes tested remained unchanged under 
conditions that precluded new enzyme synthesis, the enzyme 
levels were not the limiting factors for glucose oxidation via 
149 
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the HMP pathway. 
In order to determine if either NAD and/or NADP were 
regulating the HMP pathway activity, the staphylococcal sus-
pensions were starved for 6 hr in buffered-glucose (pH 7.0), 
under conditions that allowed the NAD to decrease and NADP to 
remain constant. During the period of starvation the initial 
NAD level decreased to 1 µmole/g and the percent of.glucose 
oxidized via the HM2 pathway decreased to 9%, reaching a value 
of 6% after 6 hr at which time the NAD content was further 
reduced to 0.5 µmole/g. When niacin was added, the NAD levels 
and the HMP activity in these cells were increased to 1.2 
urnu..Le:::; c:1.rru ..Lo-5. resueci:ive..Lv. c:1.ri:er L. nr or aaaii:iona..L in-
cubation. These results indicate that NAD is regulating the 
activity of this expandable (6 to 22%) HMP pathway, by in-
creasing NADP turnover via the transhydrogenase system. 
Any of several 1-, 2-, 3- and 4-substituted niacin analogs 
completely replaced the niacin requirement for both growth and 
the HMP pathway utilization when added at high concentration 
(ca. 1000 µg/ml) to either a synthetic medium or Vitamin-free 
Casitone supplemented with thiamine. On the basis of their 
effects on growth and on the HMP pathway the analogs were 
classified into 4 groups. The 22 group I analogs, including 
pyridine-N-oxide, pyridine-3-sulfonic acid and 3-acetylpyridine, 
stimulated both growth and the HMP pathway maximally while the 
9 group II analogs, such as picolinic acid, stimulated growth 
,.. 
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and the HMP pathway to a lesser extent. There were 13 analogs 
from group III, including 6-hydroxynicotinic acid, that were 
without effect while 4 analogs from group IV, including 6-
arninonicotinarnide, were inhibitory. Parallel experiments in 
this laboratory using labeled quinolinic acid, isoniazid and 
pyridine-N-oxide indicated that the analogs were converted to 
NAD(P) and not to their analogs. On the basis of the perme-
ability studies with the labeled compounds and 14c-niacin, it 
was suggested that the need for high concentrations of analogs 
for growth was due to the absence of active transport for these 
compounds and the analogs entered the cells .by simple passive 
by niacin. 
• 
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